# Association of Single-Nucleotide PolymorphismREX1 rs6815391, OCT4 rs13409 or rs3130932, and CTBP2 rs3740535 with Primary Lung Cancer Susceptibility: A Case-Control Study in a Chinese Population

Authors: Qi Shen; Wen-xiang Wang; Qiu-ping Xu; Wen-min Xiong; Zhi-qiang Liu; Zhi-jian Hu; Lin Cai; Fei He
Journal: Disease Markers
 (2019)

---

## Abstract

The purpose of the current study is to explore the contribution of single-nucleotide polymorphisms (SNPs) ofREX1 rs6815391, OCT4 rs13409 or rs3130932, and CTBP2 rs3740535 to the risk of lung cancer. A questionnaire survey was used to obtain basic information of the included subjects. A case control study was performed in 1121 patients and 1121 controls. All subjects were subjected to blood sampling for genomic DNA extraction and genotyping of the cancer stem cell-associated gene SNPs, including REX1 rs6815391, OCT4 rs13409 or rs3130932, and CTBP2 rs3740535 by real-time PCR. The association with the risk of primary lung cancer and interaction with environmental factors were assessed using unconditional logistic regression for the odds ratios and corresponding 95% confidence intervals. The genotype frequency distribution of OCT4 rs13409 loci was statistically significant, but there was no significant difference in the rest of the loci between lung cancer patients and healthy controls. The OCT4 gene was also related with lung cancer susceptibility in the genetic model after adjusting for lung cancer-related factors. Despite the presence of the dominant or recessive model, the four loci polymorphisms were associated with pollution near the place of residence, house type, worse ventilation situation, smoking, passive smoking, cooking oil fumes (COF), and family history of cancer, which increased the risk of lung cancer. Nonmarried status, 18.5≤BMI, COF, smoking, passive smoking, family history of cancer, and history of lung disease were independent risk factors of lung cancer susceptibility. Additionally, college degree or above, no pollution near the place of residence, protective genotype 1 or 2, and well ventilation can reduce the occurrence of lung cancer. There is an interaction between the four loci and environmental factors, and OCT4 rs13409 is a risk factor of primary lung cancer.


---

## Body

## 1. Introduction

Lung cancer is a common malignancy and the most frequent reason of malignancy-associated death worldwide; additionally, approximately 1.8 million new lung cancer patients were diagnosed in 2012, accounting for approximately 13% of total malignancy diagnoses [1]. In 2015, there were 733,000 new lung cancer cases and 660,000 cases of death in China [2]. Smoking is the key risk factor of pulmonary cancer [3]; nevertheless, despite a lower popularity of tobacco use in China, lung cancer prevalence in Chinese females is higher than in females of several European countries [1]. This indicated that other risk factors, for example genetic factors, may be part of the cause in the development of lung cancer.Lung cancer is caused by a variety of factors. Single-nucleotide polymorphisms (SNPs) play fundamental roles in tumorigenesis, cancer development, and prognosis. SNPs can modify gene product sequences, regulate gene expression, and influence gene function to change the phenotype.The pluripotency and self-renewal characteristics of embryonic cells involved multiple levels of cells and a variety of factors, and the coding of stem cell signaling molecules in the genetic polymorphism may be involved in cancer occurrence [4–6]. Cancer stem cells (CSCs) have been recognized as the major source of cancer initiation and recurrence. Elevated OCT4 expression has been reported in many tumor types including NSCLC, and the expression levels of OCT4 mRNA and protein were significantly higher in tumor tissues compared with adjacent normal tissues [7]. Researchers revealed that OCT4 is linked to chemoresistance to cisplatin in NSCLC cells, suggesting that OCT4 inhibition may be a potential strategy for chemosensitization of NSCLC cells [8]. Clinical studies further validated the importance of the OCT4/NEAT1/MALAT1 signaling axis in lung cancer progression [9].OCT4, the “core transcription factor,” plays important roles in self-renewal, tumorigenesis, invasiveness, and drug resistance of cancer stem cells [10]. OCT4 is associated with many types of cancer, including lung cancer [11], germ cell tumors [12], breast cancer [13], cervical cancer [14], prostate cancer [15], stomach cancer [16], liver cancer [17], and ovarian cancer [18]. In embryonic stem cells, OCT4 has been identified to regulate the transcriptions of other transcription factors, chromatin modifiers, long noncoding RNAs (lncRNAs), and microRNAs [19]. The OCT4gene binding inhibitory complex makes stem cells lose pluripotency. For example, miR-45 as acts as a tumor inhibitor by regulating the expression of OCT4 to reduce lung cancer initiation by tumor stem cells as well as their epithelial mesenchymal transition (epithelial-mesenchymal transition (EMT)). miR-45 also inhibited tumor growth and metastasis in lung adenocarcinoma [20]. Additionally, genes involved in the maintenance of pluripotency, such as Fgf4, Utf1, Zfp42/REX1, and Opn, are all downstream genes of OCT4 [21].REX1 regulates the growth and development of embryonic stem cells and reacts with OCT4 [22]. REX1 not only inhibits the transcriptional activation of OCT4 to induce stem cell apoptosis but also independently regulates growth inhibition, apoptotic cell death, cell cycle arrest, and DNA damage [23].The whole genome sequence analysis and functional experiments showed that the most prominent synergistic factor in the transcriptional repression complex was NuRD, and CTBP is an important ligand for the transcriptional inhibition of NuRD [24]. The combination of NuRD and CTBP2 leads to the deacetylation of embryonic stem cells and the disappearance of the pluripotency of stem cells. A new study showed that CtBP2 knockdown enhanced NSCLC cell sensitivity to CDDP through inhibition of the Wnt/β-catenin pathway, which suggests that CtBP2 depletion can provide a new target for NSCLC treatment [25]. REX1 (upstream of OCT4), CTBP2 (downstream of OCT4), and OCT4 synthetically can inhibit stem cell proliferation and regulate cancer stem cell apoptosis. We intended to explore the association between SNPS of three genes in this pathway and lung cancer susceptibility. The SNP rs13409 of the OCT4 gene showed significant associations with multiple myeloma risks from a previously published genome-wide association study (GWAS); the OCT4 rs3130932 was associated with gastric cancer and breast cancer. However, there are few studies on REX1 rs6815391 and CTBP2 rs3740535. Thus, we selected REX1 rs6815391, OCT4 rs13409, rs3130932, and CTBP2 rs3740535.


## 2. Materials and Method

### 2.1. Subjects

1121 newly diagnosed (enrolled in the study at the time of cancer diagnosis) primary lung cancer patients were recruited from three hospitals of the First Clinical Medical College of Fujian Medical University, Fuzhou General Hospital, and the Affiliated Union Hospital of Fujian Medical University, from July 2006 to February 2013. The control group consisted of 1121 age-matched (±2 years) cancer-free individuals recruited from medical examination centers or hospital nononcology departments during the same period. All subjects were Chinese Han who were living in Fujian for >10 years and were able to answer questions clearly. The response rate for subjects was 92.68%. This study was approved by the Institutional Review Board of Fujian Medical University (Fuzhou, China), and all participants signed the informed consent forms.


### 2.2. Questionnaire

A unified standard questionnaire according to the principle of informed consent was used. The investigators accepted a unified training for the face-to-face interview survey. The survey includes the general situation (age, gender, ethnicity, education, marital status, height, weight, etc.), living environment, diet history, alcohol drinking history, smoking history, tea drinking history, lung disease history, family history of cancer, and history of physical activity.The education degree was divided into three levels: primary school or below, junior and senior high school, and college degree or above. The marital status included three grades: married, others (divorced and widowed), and single. We calculated the body mass index (BMI) as body weight (kg)/height2 (m2). House types included bungalow, building, and others. There were three different ventilation situations, well, general, or worse, which was judged according to the ventilation of the bedroom. To evaluate cooking oil fume (COF) exposure, the fumes in the kitchen during cooking were classified into no fumes, little fumes, some fumes, or much fumes. Redecoration within 10 years, smoking, passive smoking, tea drinking, history of lung disease, and family history of cancer were provided with a binary response (“no” or “yes”). The kitchen ventilator was a machine that sucked cooking oil fumes out of the kitchens. Redecoration within 10 years indicated that the interior had been redecorated or painted within the last 10 years. Smoking status was defined as individuals who had smoked at least 100 cigarettes during their lifetime. Passive smoking was defined as exposure to other environmental sources of tobacco smoke at home and/or at work for more than 15 minutes per day. Drinking alcohol was defined as drinking at least once per week for more than half a year. Tea drinkers were defined as those who consumed at least 1 cup of tea per day, for at least 6 consecutive months. History of lung disease referred to a history of chronic bronchitis, emphysema, tuberculosis, and other chronic respiratory diseases. Family history of cancer was any type of cancer in any immediate family member.


### 2.3. Study Protocol

#### 2.3.1. Sample Collection and DNA Isolation

Peripheral blood samples were obtained from both patients and control subjects included in this study and stored in EDTA tubes. Protease K digestion and phenol-chloroform extraction were used to extract the genomic DNA from blood samples. The purified genomic DNA was stored at -20°C until being used for SNP genotyping.


#### 2.3.2. Genotyping

Genotyping [26] was performed at the UCLA Genotype and Sequencing Core, with a customized Fluidigm Dynamic 96.96 Array™ Assay (Fluidigm, South San Francisco, CA). The assays were based on allele-specific PCR SNP detection chemistry with Dynamic Array™ integrated fluidic circuits (IFCs). The SNP Type Assay employed tagged, allele-specific PCR primers and a common reverse primer. A universal probe set was used in every reaction, producing uniform fluorescence. Fluidigm provided locus-specific primer sequences that allowed one to confirm target locations.The genomic DNA was used for SNP genotyping with the Sequenom platform in accordance with the manufacturer’s iPLEX Application Guide (Sequenom Inc., San Diego, CA). The samples were scanned using a matrix-assisted laser desorption ionization-time of flight mass spectrometry system and genotyped with a MassARRAY Typer 3.4 (Sequenom Inc., San Diego, CA). For quality control, approximately 10% of randomly selected samples were rerun. The concordance rate was 99.5%, and the genotyping call rates reached >90%.


### 2.4. Statistical Analysis

IBM SPSS 21.0 software (Armonk, NY, USA) was used, and the statistical significance was set to 0.05. Demographic features between lung cancer patients and healthy controls were compared by a 2-sided chi-squared test to identify the potential differences. An online calculator withα of 0.05 was used to evaluate the Hardy-Weinberg equilibrium for each SNP. The odds ratio (OR) was calculated with an unconditional logistic regression model, and the risk of lung cancer developing for polymorphisms among study subjects was estimated by 95% confidence interval (CI); the possible confounding factors, for example age and education, were controlled to analyze the adjusted OR. The relative excess risk because of interaction, the attributable proportion because of interaction, the synergy index, and its 95% CI were used to evaluate the association between the four SNPs and lung cancer.


### 2.5. Ethics Statement

Our study was approved by the Ethical Committee of Fujian Medical University (Fuzhou, China) ([2014] Fu Yi Ethics Review (No. 98)), and all participants signed the informed consent forms.


## 2.1. Subjects

1121 newly diagnosed (enrolled in the study at the time of cancer diagnosis) primary lung cancer patients were recruited from three hospitals of the First Clinical Medical College of Fujian Medical University, Fuzhou General Hospital, and the Affiliated Union Hospital of Fujian Medical University, from July 2006 to February 2013. The control group consisted of 1121 age-matched (±2 years) cancer-free individuals recruited from medical examination centers or hospital nononcology departments during the same period. All subjects were Chinese Han who were living in Fujian for >10 years and were able to answer questions clearly. The response rate for subjects was 92.68%. This study was approved by the Institutional Review Board of Fujian Medical University (Fuzhou, China), and all participants signed the informed consent forms.


## 2.2. Questionnaire

A unified standard questionnaire according to the principle of informed consent was used. The investigators accepted a unified training for the face-to-face interview survey. The survey includes the general situation (age, gender, ethnicity, education, marital status, height, weight, etc.), living environment, diet history, alcohol drinking history, smoking history, tea drinking history, lung disease history, family history of cancer, and history of physical activity.The education degree was divided into three levels: primary school or below, junior and senior high school, and college degree or above. The marital status included three grades: married, others (divorced and widowed), and single. We calculated the body mass index (BMI) as body weight (kg)/height2 (m2). House types included bungalow, building, and others. There were three different ventilation situations, well, general, or worse, which was judged according to the ventilation of the bedroom. To evaluate cooking oil fume (COF) exposure, the fumes in the kitchen during cooking were classified into no fumes, little fumes, some fumes, or much fumes. Redecoration within 10 years, smoking, passive smoking, tea drinking, history of lung disease, and family history of cancer were provided with a binary response (“no” or “yes”). The kitchen ventilator was a machine that sucked cooking oil fumes out of the kitchens. Redecoration within 10 years indicated that the interior had been redecorated or painted within the last 10 years. Smoking status was defined as individuals who had smoked at least 100 cigarettes during their lifetime. Passive smoking was defined as exposure to other environmental sources of tobacco smoke at home and/or at work for more than 15 minutes per day. Drinking alcohol was defined as drinking at least once per week for more than half a year. Tea drinkers were defined as those who consumed at least 1 cup of tea per day, for at least 6 consecutive months. History of lung disease referred to a history of chronic bronchitis, emphysema, tuberculosis, and other chronic respiratory diseases. Family history of cancer was any type of cancer in any immediate family member.


## 2.3. Study Protocol

### 2.3.1. Sample Collection and DNA Isolation

Peripheral blood samples were obtained from both patients and control subjects included in this study and stored in EDTA tubes. Protease K digestion and phenol-chloroform extraction were used to extract the genomic DNA from blood samples. The purified genomic DNA was stored at -20°C until being used for SNP genotyping.


### 2.3.2. Genotyping

Genotyping [26] was performed at the UCLA Genotype and Sequencing Core, with a customized Fluidigm Dynamic 96.96 Array™ Assay (Fluidigm, South San Francisco, CA). The assays were based on allele-specific PCR SNP detection chemistry with Dynamic Array™ integrated fluidic circuits (IFCs). The SNP Type Assay employed tagged, allele-specific PCR primers and a common reverse primer. A universal probe set was used in every reaction, producing uniform fluorescence. Fluidigm provided locus-specific primer sequences that allowed one to confirm target locations.The genomic DNA was used for SNP genotyping with the Sequenom platform in accordance with the manufacturer’s iPLEX Application Guide (Sequenom Inc., San Diego, CA). The samples were scanned using a matrix-assisted laser desorption ionization-time of flight mass spectrometry system and genotyped with a MassARRAY Typer 3.4 (Sequenom Inc., San Diego, CA). For quality control, approximately 10% of randomly selected samples were rerun. The concordance rate was 99.5%, and the genotyping call rates reached >90%.


## 2.3.1. Sample Collection and DNA Isolation

Peripheral blood samples were obtained from both patients and control subjects included in this study and stored in EDTA tubes. Protease K digestion and phenol-chloroform extraction were used to extract the genomic DNA from blood samples. The purified genomic DNA was stored at -20°C until being used for SNP genotyping.


## 2.3.2. Genotyping

Genotyping [26] was performed at the UCLA Genotype and Sequencing Core, with a customized Fluidigm Dynamic 96.96 Array™ Assay (Fluidigm, South San Francisco, CA). The assays were based on allele-specific PCR SNP detection chemistry with Dynamic Array™ integrated fluidic circuits (IFCs). The SNP Type Assay employed tagged, allele-specific PCR primers and a common reverse primer. A universal probe set was used in every reaction, producing uniform fluorescence. Fluidigm provided locus-specific primer sequences that allowed one to confirm target locations.The genomic DNA was used for SNP genotyping with the Sequenom platform in accordance with the manufacturer’s iPLEX Application Guide (Sequenom Inc., San Diego, CA). The samples were scanned using a matrix-assisted laser desorption ionization-time of flight mass spectrometry system and genotyped with a MassARRAY Typer 3.4 (Sequenom Inc., San Diego, CA). For quality control, approximately 10% of randomly selected samples were rerun. The concordance rate was 99.5%, and the genotyping call rates reached >90%.


## 2.4. Statistical Analysis

IBM SPSS 21.0 software (Armonk, NY, USA) was used, and the statistical significance was set to 0.05. Demographic features between lung cancer patients and healthy controls were compared by a 2-sided chi-squared test to identify the potential differences. An online calculator withα of 0.05 was used to evaluate the Hardy-Weinberg equilibrium for each SNP. The odds ratio (OR) was calculated with an unconditional logistic regression model, and the risk of lung cancer developing for polymorphisms among study subjects was estimated by 95% confidence interval (CI); the possible confounding factors, for example age and education, were controlled to analyze the adjusted OR. The relative excess risk because of interaction, the attributable proportion because of interaction, the synergy index, and its 95% CI were used to evaluate the association between the four SNPs and lung cancer.


## 2.5. Ethics Statement

Our study was approved by the Ethical Committee of Fujian Medical University (Fuzhou, China) ([2014] Fu Yi Ethics Review (No. 98)), and all participants signed the informed consent forms.


## 3. Results

### 3.1. Demographic Characteristics and Environmental Factors

The demographic characteristics of 1121 patients and 1121 controls are listed in Table1. There were no significant differences (P>0.05) between the patient group and control group including age, gender, redecoration within 10 years, and drinking tea. However, there was a significant difference in the distribution of the educational history, marital status, BMI, pollution near the place of residence, house type, ventilation situation, COF, kitchen ventilator, smoking, passive smoking, drinking alcohol, history of lung disease, and family history of cancer between cases and controls (P<0.05) (Table 1).Table 1
Demographic characteristics of the included patients and healthy control.
Variable
Case group (%)
Control group (%)
OR (95% CI)
Age
≤52
295 (26.3)
289 (25.8)
1.000
53-59
285 (25.4)
273 (24.4)
1.012 (0.802-1.278)
60-66
272 (24.3)
274 (24.4)
0.973 (0.770-1.228)
≥67
269 (24.0)
285 (25.4)
0.925 (0.733-1.167)
Gender
Male
797 (71.1)
797 (71.1)
1.000
Female
324 (28.9)
324 (28.9)
1.000 (0.833-1.200)
Degree of education
Primary school or below
564 (50.4)
418 (37.3)
1.000
Junior and senior high school
443 (39.6)
553 (49.3)
0.594 (0.497-0.709)
College degree or above
114 (10.2)
150 (13.4)
0.563 (0.428-0.741)
Marital status
Married
1054 (94.0)
1039 (92.7)
1.000
Others
64 (5.7)
66 (5.9)
0.956 (0.671-1.362)
Single
3 (0.3)
16 (1.4)
0.185 (0.054-0.636)
BMI (kg/m2)
<18.5
124 (11.1)
51 (4.5)
1.000
18.5-23.9
694 (61.9)
613 (54.7)
0.466 (0.330-0.657)
≥24
303 (27.0)
457 (40.8)
0.273 (0.191-0.390)
Pollution near the place of residence
Not
900 (80.3)
1026 (91.5)
1.000
Exist
221 (19.7)
95 (8.5)
2.652 (2.052-3.428)
House type
Bungalow
377 (33.6)
182 (16.2)
1.000
Building
734 (65.5)
931 (83.1)
0.381 (0.311-0.466)
Others
10 (0.9)
8 (0.7)
0.603 (0.234-1.555)
Ventilation situation
Well
859 (76.6)
990 (88.3)
1.000
General
223 (19.9)
115 (10.3)
2.235 (1.753-2.849)
Worse
39 (3.5)
16 (1.4)
2.809 (1.559-5.063)
Cooking oil fume (COF)
No
190 (16.9)
350 (31.2)
1.000
Little
613 (54.7)
544 (48.5)
2.076 (1.681-2.563)
Some
269 (24.0)
205 (18.3)
2.417 (1.876-3.114)
Much
49 (4.4)
22 (2.0)
4.103 (2.407-6.992)
Kitchen ventilator
No
480 (42.8)
337 (30.1)
1.000
Yes
641 (57.2)
784 (69.9)
0.574 (0.482-0.683)
Decoration within 10 years
No
674 (60.1)
692 (61.7)
1.000
Yes
447 (39.9)
429 (38.3)
1.070 (0.903-1.268)
Smoking
No
425 (37.9)
659 (58.8)
1.000
Yes
696 (62.1)
462 (41.2)
2.336 (1.972-2.767)
Passive smoking
No
335 (29.9)
621 (55.4)
1.000
Yes
786 (70.1)
500 (44.6)
2.914 (2.449-3.467)
Drink alcohol
No
733 (65.4)
805 (71.8)
1.000
Yes
388 (34.6)
316 (28.2)
1.348 (1.127-1.613)
Drink tea
No
566 (50.5)
537 (47.9)
1.000
Yes
555 (49.5)
584 (52.1)
0.902 (0.764-1.064)
History of lung disease
No
983 (87.7)
1025 (91.4)
1.000
Yes
138 (12.3)
96 (8.6)
1.499 (1.139-1.973)
Family history of cancer
No
900 (80.3)
950 (84.7)
1.000
Yes
221 (19.7)
171 (15.3)
1.364 (1.095-1.699)
BMI = weight (kg)/height2 (m2).


### 3.2. The Relationship between the Four SNPs and Susceptibility to Lung Cancer

The results of unconditional logistic regression analysis showed that there was no association betweenREX1 rs6815391, OCT4 rs3130932, or CTBP2 rs3740535 polymorphisms with susceptibility to lung cancer after adjusting for lung cancer-related factors, whether in co-dominant or dominant, recessive, additive, or genetic models. Only OCT4 rs13409 was associated with lung cancer occurrence. In the co-dominant model, the lung cancer risk of the OCT4 rs13409 CT genotype carriers was 0.731-fold that of the CC genotype carriers (95% CI: 0.595-0.899, P<0.05); in the dominant model, the risk of lung cancer in the CT+TT genotype carriers was 0.765-fold that of the CC carriers (95% CI: 0.629-0.930, P<0.05) (Tables 2 and 3).Table 2
Association of rs13409 SNP with susceptibility to lung cancer.
Genotyping
Case (%)
Control (%)
OR (95% CI)
a(OR (95% CI)#
N=1022
N=1053
Codominant
CC
512 (50.1)
466 (44.3)
1.000
1.000
CT
389 (38.1)
478 (45.4)
0.741 (0.617-0.890)
0.731 (0.595-0.899)
TT
121 (11.8)
109 (10.3)
1.010 (0.758-1.347)
0.908 (0.657-1.257)
Dominant
CC
512 (50.1)
466 (44.3)
1.000
1.000
CT+TT
510 (49.9)
587 (55.7)
0.791 (0.665-0.940)
0.765 (0.629-0.930)
Recessive
CC+CT
901 (88.2)
944 (89.7)
1.000
1.000
TT
121 (11.8)
109 (10.3)
1.163 (0.884-1.530)
1.054 (0.774-1.436)
Additive
0.908 (0.799-1.032)
0.873 (0.755-1.009)
#By the degree of education, marital status, BMI, pollution near the place of residence, house type, ventilation situation, COF, kitchen ventilator, smoking, passive smoking, drink alcohol, history of lung disease, and family history of cancer adjusted. OR and its interval shown in italic font to represent P<0.05.Table 3
Association of another three SNPs with susceptibility to lung cancer.
Classification
Case (%)
Control (%)
OR (95% CI)
aOR (95% CI)#
N=1020
N=1033
rs6815391PHWE=0.099
Codominant
TT
477 (46.8)
472 (45.7)
1.000
1.000
CT
438 (42.9)
435 (42.1)
0.996 (0.829-1.197)
0.901 (0.732-1.109)
CC
105 (10.3)
126 (12.2)
0.825 (0.618-1.100)
0.925 (0.670-1.279)
Dominant
TT
477 (46.8)
472 (45.7)
1.000
1.000
CT+CC
543 (53.2)
561 (54.3)
0.958 (0.805-1.139)
0.906 (0.745-1.102)
Recessive
TT+CT
915 (89.7)
907 (87.8)
1.000
1.000
CC
105 (10.3)
126 (12.2)
0.826 (0.628-1.087)
0.973 (0.715-1.323)
Additive
0.936 (0.823-1.065)
0.942 (0.814-1.089)
rs3740535PHWE=0.890
Codominant
GG
602 (57.4)
614 (56.9)
1.000
1.000
AG
373 (35.6)
401 (37.1)
0.949 (0.792-1.136)
0.916 (0.747-1.124)
AA
73 (7.0)
64 (6.0)
1.163 (0.817-1.657)
1.067 (0.714-1.594)
Dominant
GG
602 (57.4)
614 (56.9)
1.000
1.000
AG+AA
446 (42.6)
465 (43.1)
0.978 (0.824-1.162)
0.937 (0.772-1.139)
Recessive
AG+GG
975 (93.0)
1015 (94.0)
1.000
1.000
AA
73 (7.0)
64 (6.0)
1.187 (0.839-1.680)
1.103 (0.744-1.636)
Additive
1.013 (0.882-1.163)
0.974 (0.833-1.139)
rs3130932PHWE=0.986
Codominant
TT
453 (43.4)
453 (41.8)
1.000
1.000
GT
460 (44.0)
494 (45.7)
0.931 (0.776-1.117)
0.890 (0.725-1.093)
GG
132 (12.6)
135 (12.5)
0.978 (0.744-1.285)
1.031 (0.757-1.404)
Dominant
TT
453 (43.4)
453 (41.8)
1.000
1.000
GT+GG
592 (56.6)
629 (58.2)
0.941 (0.793-1.118)
0.919 (0.757-1.116)
Recessive
GT+TT
913 (87.4)
947 (87.5)
1.000
1.000
GG
132 (12.6)
135 (12.5)
1.014 (0.785-1.311)
1.095 (0.819-1.463)
Additive
0.972 (0.857-1.101)
0.977 (0.848-1.125)
#By the degree of education, marital status, BMI, pollution near the place of residence, house type, ventilation situation, COF, kitchen ventilator, smoking, passive smoking, drink alcohol, history of lung disease, and family history of cancer adjusted.


### 3.3. Pathological Stratification Analysis

There was no significant difference betweenCTBP2 rs3740535 and REX1 rs6815391 polymorphism with lung cancer occurrence regardless of adenocarcinoma, squamous, or any type of lung cancer.For the adenocarcinoma patients withOCT4 rs13409, the risk of lung cancer in CT genotype carriers was 0.689-fold (95% CI: 0.536-0.885, P<0.05) that of the CC carriers according to the co-dominant model; the lung cancer risk of CT+TT carriers was 0.745-fold that of the CC carriers (95% CI: 0.589-0.941, P<0.05) by the dominant model. For all lung cancer types with OCT4 rs13409, a risk of lung cancer in the CT genotype carriers was 0.734-fold (95% CI: 0.610-0.884, P<0.05) that of the CC carriers according to the co-dominant model; the lung cancer risk of CT+TT carriers was 0.781-fold that of the CC carriers (95% CI: 0.656-0.930, P<0.05).Regarding squamous cell carcinoma, the risk of lung cancer inOCT4 rs3130932 GG carriers was 1.569-fold (95% CI: 1.016-2.425, P<0.05) that of the GT+TT carriers according to the recessive models (Table 4).Table 4
Association of the four SNPs of different pathological types with susceptibility to lung cancer.
Lung adenocarcinoma
Lung squamous cell carcinoma
Total
Classification
Case/control
aOR (95% CI)#
Case/control
aOR (95% CI)#
Case/control
aOR (95% CI)#
rs13409Codominant
CC
252/466
1.000
147/466
1.000
490/466
1.000
CT
177/478
0.689 (0.536-0.885)
109/478
0.756 (0.543-1.053)
369/478
0.734 (0.610-0.884)
TT
58/109
0.987 (0.672-1.450)
30/109
0.754 (0.444-1.282)
113/109
0.986 (0.736-1.320)
rs13409Dominant
CC
352/466
1.000
147/466
1.000
490/466
1.000
CT+TT
235/587
0.745 (0.589-0.941)
139/587
0.756 (0.553-1.033)
482/587
0.781 (0.656-0.930)
rs13409Recessive
CC+CT
429/944
1.000
256/944
1.000
859/944
1.000
TT
58/109
1.171 (0.811-1.692)
30/109
0.861 (0.518-1.430)
859/109
1.039 (0.862-1.506)
rs13409Additive
0.879 (0.737-1.048)
0.827 (0.653-1.047)
0.897 (0.788-1.022)
rs6815391Codominant
TT
230/472
1.000
136/472
1.000
452/472
1.000
CT
205/435
0.905 (0.705-1.161)
125/435
1.028 (0.740-1.428)
418/435
1.003 (0.833-1.209)
CC
49/126
0.836 (0.562-1.241)
26/126
0.830 (0.482-1.429)
101/126
0.837 (0.625-1.121)
rs6815391Dominant
TT
230/472
1.000
136/472
1.000
452/472
1.000
CT+CC
254/561
0.890 (0.703-1.126)
151/561
0.986 (0.722-1.348)
519/561
0.966 (0.810-1.152)
rs6815391Recessive
TT+CT
435/907
1.000
261/907
1.000
870/907
1.000
CC
49/126
0.876 (0.600-1.278)
26/126
0.819 (0.488-1.377)
101/126
0.836 (0.633-1.103)
rs6815391Additive
0.911 (0.764-1.086)
0.952 (0.752-1.204)
0.943 (0.828-1.074)
rs3740535Codominant
GG
295/614
1.000
159/614
1.000
571/614
1.000
AG
169/401
0.875 (0.683-1.123)
114/401
1.034 (0.748-1.430)
354/401
0.949 (0.791-1.140)
AA
35/64
0.968 (0.598-1.567)
19/64
1.243 (0.650-2.375)
72/64
1.210 (0.848-1.726)
rs3740535Dominant
GG
295/614
1.000
159/614
1.000
571/614
1.000
GA+AA
204/465
0.889 (0.702-1.126)
133/465
1.061 (0.778-1.447)
426/465
0.985 (0.828-1.172)
rs3740535Recessive
GA+GG
464/1015
1.000
273/1015
1.000
925/1015
1.000
AA
35/64
1.018 (0.634-1.632)
19/64
1.226 (0.650-2.314)
72/64
1.234 (0.871-1.749)
rs3740535Additive
0.930 (0.769-1.124)
1.073 (0.834-1.381)
1.024 (0.891-1.178)
rs3130932Codominant
TT
228/453
1.000
119/453
1.000
432/453
1.000
GT
213/494
0.786 (0.613-1.008)
124/494
1.030 (0.737-1.440)
438/494
0.930 (0.773-1.118)
GG
57/135
0.893 (0.611-1.307)
46/135
1.593 (0.999-2.541)
125/135
0.971 (0.736-1.280)
rs3130932Dominant
TT
228/453
1.000
119/453
1.000
432/453
1.000
GT+GG
270/629
0.807 (0.639-1.021)
170/629
1.146 (0.838-1.567)
563/629
0.939 (0.789-1.117)
rs3130932Recessive
GT+TT
441/947
1.000
243/947
1.000
870/947
1.000
GG
57/135
1.009 (0.705-1.446)
46/135
1.569 (1.016-2.425)
125/135
1.008 (0.777-1.307)
rs3130932Additive
0.894 (0.752-1.064)
1.201 (0.961-1.501)
0.969 (0.853-1.100)
#By the degree of education, marital status, BMI, pollution near the place of residence, house type, ventilation situation, COF, kitchen ventilator, smoking, passive smoking, drink alcohol, history of lung disease, and family history of cancer adjusted. OR and its interval shown in italic font to represent the P<0.05.


### 3.4. Combination and Interaction Analysis

We analyzed the interactions between the four genotypes and the environment factors including pollution near the place of residence, house type, COF, ventilation situation, kitchen ventilator, smoking, passive smoking, drink alcohol, history of lung disease, and family history of cancer (Tables5 and 6).Table 5
Joint and multiplication interaction between gene dominant model and environmental factors.
Genotype
Environment
Case (%)
Control (%)
OR (95% CI)
aOR (95% CI)#
rs13409
N=1022
N=1053
rs13409 with pollution near the place of residence
CC
No
414 (40.5)
429 (40.7)
1.000
1.000
CC
Yes
98 (9.6)
37 (3.5)
2.745 (1.837-4.101)
2.467 (1.595-3.816)
CT+TT
No
410 (40.1)
540 (51.3)
0.787 (0.653-0.948)
0.760 (0.617-0.936)
CT+TT
Yes
100 (9.8)
47 (4.5)
2.205 (1.520-3.198)
1.980 (1.316-2.977)
rs13409 × pollution near the place of residence
ORmultiply (95% CI)
2.322 (1.623-3.321)
2.119 (1.432-3.138)
rs13409 with house type
CC
No
174 (17.0)
80 (7.6)
1.000
1.000
CC
Yes
338 (33.1)
386 (36.7)
0.403 (0.298-0.545)
0.504 (0.358-0.711)
CT+TT
No
174 (17.0)
93 (8.8)
0.860 (0.597-1.240)
0.761 (0.510-1.136)
CT+TT
Yes
336 (32.9)
494 (46.9)
0.313 (0.232-0.422)
0.387 (0.276-0.542)
rs13409 × house type
ORmultiply (95% CI)
0.554 (0.464-0.662)
0.627 (0.513-0.766)
rs13409 with ventilation situation
CC
No
17 (1.7)
8 (0.8)
1.000
1.000
CC
Yes
495 (48.4)
458 (43.5)
0.509 (0.217-1.190)
0.654 (0.257-1.665)
CT+TT
No
19 (1.9)
7 (0.7)
1.277 (0.382-4.271)
1.305 (0.350-4.862)
CT+TT
Yes
491 (48.0)
580 (55.1)
0.398 (0.170-1.931)
0.497 (0.196-1.264)
rs13409 × ventilation situation
ORmultiply (95% CI)
0.754 (0.635-0.896)
0.652 (0.533-0.798)
rs13409 with kitchen ventilator
CC
No
215 (21.0)
138 (13.1)
1.000
1.000
CC
Yes
297 (29.1)
328 (31.1)
0.581 (0.446-0.758)
0.973 (0.712-1.330)
CT+TT
No
224 (21.9)
177 (16.8)
0.812 (0.607-1.086)
0.808 (0.583-1.120)
CT+TT
Yes
286 (28.0)
410 (38.9)
0.448 (0.345-0.582)
0.722 (0.530-0.984)
rs13409 × kitchen ventilator
ORmultiply (95% CI)
0.609 (0.507-0.733)
0.771 (0.623-0.954)
rs13409 with COF
CC
No
84 (8.2)
153 (14.5)
1.000
1.000
CC
Yes
428 (41.9)
313 (29.7)
2.491 (1.839-3.374)
2.101 (1.497-2.949)
CT+TT
No
88 (8.6)
182 (17.3)
0.881 (0.609-1.273)
0.855 (0.569-1.286)
CT+TT
Yes
422 (41.3)
405 (38.5)
1.898 (1.407-2.559)
1.572 (1.124-2.197)
rs13409 × COF
ORmultiply (95% CI)
1.125 (0.944-1.342)
0.890 (0.837-0.946)
rs13409 with smoking
CC
No
202 (19.8)
264 (25.1)
1.000
1.000
CC
Yes
310 (30.3)
202 (19.2)
2.006 (1.554-2.588)
1.657 (1.231-2.230)
CT+TT
No
189 (18.5)
361 (34.3)
0.684 (0.531-0.882)
0.641 (0.485-0.849)
CT+TT
Yes
321 (31.4)
226 (21.5)
1.856 (1.446-2.384)
1.496 (1.113-2.011)
rs13409 × smoking
ORmultiply (95% CI)
1.676 (1375-2.042)
1.374 (1.093-1.727)
rs13409 with passive smoking
CC
No
156 (15.3)
267 (25.4)
1.000
1.000
CC
Yes
356 (34.8)
199 (18.9)
3.062 (2.354-3.982)
2.404 (1.081-3.209)
CT+TT
No
151 (14.8)
317 (30.1)
0.815 (0.618-1.075)
0.766 (0.567-1.037)
CT+TT
Yes
359 (35.1)
270 (25.6)
2.276 (1.767-2.930)
1.837 (1.392-2.423)
rs13409 × passive smoking
ORmultiply (95% CI)
1.570 (1.300-1.897)
1.402 (1.138-1.727)
rs13409 with drink alcohol
CC
No
343 (33.6)
329 (31.2)
1.000
1.000
CC
Yes
169 (16.5)
137 (13.0)
1.183 (0.902-1.552)
0.800 (0.581-1.100)
CT+TT
No
328 (32.1)
421 (40.0)
0.747 (0.606-0.921)
0.736 (0.581-0.932)
CT+TT
Yes
182 (17.8)
166 (15.8)
1.052 (0.812-1.363)
0.665 (0.492-0.900)
rs13409 × drink alcohol
ORmultiply (95% CI)
1.158 (0.919-1.458)
0.793 (0.608-1.034)
rs13409 with history of lung disease
CC
No
452 (44.2)
422 (40.1)
1.000
1.000
CC
Yes
60 (5.9)
44 (4.2)
1.273 (0.844-1.920)
1.087 (0.680-1.737)
CT+TT
No
442 (43.2)
542 (51.5)
0.761 (0.634-0.914)
0.724 (0.589-0.889)
CT+TT
Yes
68 (6.7)
45 (4.3)
1.411 (0.946-2.103)
1.364 (0.866-2.147)
rs13409 × history of lung disease
ORmultiply (95% CI)
1.597 (1.084-2.351)
1.596 (1.028-2.477)
rs13409 with family history of cancer
CC
No
403 (39.4)
395 (37.5)
1.000
1.000
CC
Yes
109 (10.7)
71 (6.7)
1.505 (1.082-2.092)
1.495 (1.032-2.167)
CT+TT
No
412 (40.3)
501 (47.6)
0.806 (0.666-0.975)
0.769 (0.620-0.953)
CT+TT
Yes
98 (9.6)
86 (8.2)
1.117 (0.810-1.540)
1.116 (0.777-1.603)
rs13409 × family history of cancer
ORmultiply (95% CI)
1.193 (0.881-1.615)
1.218 (0.865-1.714)
rs6815391
N=1020
N=1033
rs6815391 with pollution near the place of residence
TT
No
385 (37.7)
425 (41.1)
1.000
1.000
TT
Yes
92 (9.0)
47 (4.5)
2.161 (1.481-3.152)
1.978 (1.311-2.984)
CT+CC
No
436 (42.7)
522 (50.5)
0.922 (0.764-1.112)
0.862 (0.699-1.064)
CT+CC
Yes
107 (10.5)
39 (3.8)
3.029 (2.047-4.481)
2.516 (1.647-3.845)
rs6815391 × pollution near the place of residence
ORmultiply (95% CI)
2.987 (2.048-4.357)
2.571 (1.710-3.865)
rs6815391 with house type
TT
No
140 (13.7)
73 (7.1)
1.000
1.000
TT
Yes
337 (33.0)
399 (38.6)
0.440 (0.320-0.605)
0.638 (0.444-0.915)
CT+CC
No
194 (19.0)
92 (8.9)
1.100 (0.755-1.602)
1.212 (0.802-1.832)
CT+CC
Yes
349 (34.2)
469 (45.4)
0.388 (0.283-0.532)
0.532 (0.371-0.762)
rs6815391 × house type
ORmultiply (95% CI)
0.625 (0.523-0.747)
0.679 (0.554-0.832)
rs6815391 with ventilation situation
TT
No
15 (1.5)
9 (0.9)
1.000
1.000
TT
Yes
462 (45.3)
463 (44.8)
0.599 (0.259-1.382)
0.668 (0.268-1.667)
CT+CC
No
23 (2.3)
6 (0.6)
2.300 (0.679-7.796)
1.831 (0.481-6.966)
CT+CC
Yes
520 (51.0)
555 (53.7)
0.562 (0.244-1.296)
0.599 (0.241-1.493)
rs6815391 × ventilation situation
ORmultiply (95% CI)
0.896 (0.753-1.065)
0.791 (0.645-0.969)
rs6815391 with kitchen ventilator
TT
No
209 (20.5)
143 (13.8)
1.000
1.000
TT
Yes
268 (26.3)
329 (31.8)
0.557 (0.427-0.728)
0.866 (0.632-1.187)
CT+CC
No
226 (22.2)
164 (15.9)
0.943 (0.704-1.263)
0.834 (0.602-1.156)
CT+CC
Yes
317 (31.1)
397 (38.4)
0.546 (0.422-0.708)
0.823 (0.607-1.114)
rs6815391 × kitchen ventilator
ORmultiply (95% CI)
0.722 (0.602-0.867)
0.927 (0.752-1.144)
rs6815391 with COF
TT
No
89 (8.7)
158 (15.3)
1.000
1.000
TT
Yes
388 (38.0)
314 (30.4)
2.194 (1.626-2.959)
1.824 (1.308-2.544)
CT+CC
No
86 (8.4)
179 (17.3)
0.853 (0.592-1.229)
0.812 (0.542-1.216)
CT+CC
Yes
457 (44.8)
382 (37.0)
2.124 (1.584-2.847)
1.716 (1.239-2.375)
rs6815391 × COF
ORmultiply (95% CI)
1.383 (1.159-1.651)
0.932 (0.876-0.992)
rs6815391 with smoking
TT
No
192 (18.8)
265 (25.7)
1.000
1.000
TT
Yes
285 (27.9)
207 (20.0)
1.900 (1.468-2.460)
1.644 (1.217-2.220)
CT+CC
No
196 (19.2)
353 (34.2)
0.766 (0.594-0.989)
0.727 (0.550-0.962)
CT+CC
Yes
347 (34.0)
208 (20.1)
2.303 (1.788-2.966)
1.839 (1.372-2.463)
rs6815391 × smoking
ORmultiply (95% CI)
2.045 (1.675-2.497)
1.650 (1.316-2.069)
rs6815391 with passive smoking
TT
No
138 (13.5)
258 (25.0)
1.000
1.000
TT
Yes
339 (33.2)
214 (20.7)
2.962 (2.265-3.873)
2.373 (1.771-3.180)
CT+CC
No
173 (17.0)
316 (30.6)
1.024 (0.755-1.351)
0.941 (0.695-1.274)
CT+CC
Yes
370 (36.3)
245 (23.7)
2.823 (2.172-3.670)
2.092 (1.571-2.787)
rs6815391 × passive smoking
ORmultiply (95% CI)
1.831 (1.511-2.218)
1.503 (1.216-1.857)
rs6815391 with drinking alcohol
TT
No
318 (31.2)
330 (31.9)
1.000
1.000
TT
Yes
159 (15.6)
142 (13.7)
1.162 (0.884-1.528)
0.728 (0.529-1.003)
CT+CC
No
356 (34.9)
419 (40.6)
0.882 (0.715-1.087)
0.817 (0.645-1.034)
CT+CC
Yes
187 (18.3)
142 (13.7)
1.367 (1.046-1.785)
0.831 (0.608-1.137)
rs6815391 × drink alcohol
ORmultiply (95% CI)
1.409 (1.111-1.787)
0.978 (0.743-1.287)
rs6815391 with history of lung disease
TT
No
419 (41.1)
436 (42.2)
1.000
1.000
TT
Yes
58 (5.7)
36 (3.5)
1.676 (1.083-2.595)
1.401 (0.851-2.306)
CT+CC
No
477 (46.8)
520 (50.3)
0.955 (0.795-1.146)
0.888 (0.723-1.090)
CT+CC
Yes
66 (6.5)
41 (4.0)
1.675 (1.109-2.529)
1.560 (0.977-2.490)
rs6815391× history of lung disease
ORmultiply (95% CI)
1.674 (1.122-2.496)
1.633 (1.037-2.570)
rs6815391 with family history of cancer
TT
No
385 (37.7)
400 (38.7)
1.000
1.000
TT
Yes
92 (9.0)
72 (7.0)
1.328 (0.946-1.863)
1.350 (0.923-1.975)
CT+CC
No
433 (42.5)
476 (46.1)
0.945 (0.781-1.144)
0.887 (0.715-1.101)
CT+CC
Yes
110 (10.8)
85 (8.2)
1.345 (0.980-1.844)
1.353 (0.949-1.929)
rs6815391 × family history of cancer
ORmultiply (95% CI)
1.348 (1.001-1.815)
1.396 (1.000-1.948)
rs3740535
N=1048
N=1079
rs3740535 with pollution near the place of residence
GG
No
464 (44.3)
561 (52.0)
1.000
1.000
GG
Yes
138 (13.2)
53 (4.9)
3.148 (2.241-4.422)
2.846 (1.969-4.115)
GA+AA
No
376 (35.9)
431 (39.9)
1.055 (0.877-1.269)
0.971 (0.789-1.194)
GA+AA
Yes
70 (6.7)
34 (3.2)
2.489 (1.623-3.818)
2.045 (1.276-3.278)
rs3740535 × pollution near the place of residence
ORmultiply (95% CI)
2.200 (1.447-3.344)
1.873 (1.180-2.973)
rs3740535 with house type
GG
No
204 (19.5)
85 (7.9)
1.000
1.000
GG
Yes
398 (38.0)
529 (49.0)
0.313 (0.236-0.417)
0.398 (0.288-0.548)
GA+AA
No
151 (14.4)
93 (8.6)
0.677 (0.471-0.971)
0.618 (0.415-0.920)
GA+AA
Yes
295 (28.1)
372 (34.5)
0.330 (0.246-0.444)
0.425 (0.305-0.593)
rs3740535 × house type
ORmultiply (95% CI)
0.745 (0.619-0.895)
0.845 (0.686-1.040)
rs3740535 with ventilation situation
GG
No
21 (2.0)
10 (0.9)
1.000
1.000
GG
Yes
581 (55.4)
604 (56.0)
0.458 (0.214-0.981)
0.529 (0.227-1.228)
GA+AA
No
18 (1.7)
6 (0.6)
1.429 (0.434-4.705)
1.127 (0.309-4.108)
GA+AA
Yes
428 (40.8)
459 (42.5)
0.444 (0.207-0.954)
0.490 (0.210-1.144)
rs3740535 × ventilation situation
ORmultiply (95% CI)
0.932 (0.785-1.108)
0.800 (0.652-0.980)
rs3740535 with kitchen ventilator
GG
No
249 (23.8)
162 (15.0)
1.000
1.000
GG
Yes
353 (33.7)
452 (41.9)
0.508 (0.399-0.647)
0.809 (0.608-1.076)
GA+AA
No
201 (19.2)
162 (15.0)
0.807 (0.606-1.075)
0.758 (0.550-1.045)
GA+AA
Yes
245 (23.4)
303 (28.1)
0.526 (0.406-0.682)
0.858 (0.632-1.164)
rs3740535 × kitchen ventilator
ORmultiply (95% CI)
0.781 (0.643-0.950)
1.024 (0.819-1.281)
rs3740535 with COF
GG
No
103 (9.8)
211 (19.6)
1.000
1.000
GG
Yes
499 (47.6)
403 (37.3)
2.537 (1.937-3.322)
2.217 (1.641-2.994)
GA+AA
No
77 (7.3)
131 (12.1)
1.204 (0.834-1.738)
1.272 (0.846-1.911)
GA+AA
Yes
369 (35.2)
334 (31.0)
2.263 (1.714-2.989)
1.895 (1.387-2.590)
rs3740535 × COF
ORmultiply (95% CI)
1.212 (1.012-1.453)
0.965 (0.907-1.027)
rs3740535 with smoking
GG
No
246 (23.5)
361 (33.5)
1.000
1.000
GG
Yes
356 (34.0)
253 (23.4)
2.065 (1.643-2.595)
1.729 (1.322-2.261)
GA+AA
No
154 (14.7)
274 (25.4)
0.825 (0.639-1.065)
0.806 (0.608-1.069)
GA+AA
Yes
292 (27.9)
191 (17.7)
2.243 (1.758-2.863)
1.861 (1.395-2.482)
rs3740535 × smoking
ORmultiply (95% CI)
1.796 (1.461-2.208)
1.506 (1.187-1.909)
rs3740535 with passive smoking
GG
No
179 (17.1)
350 (32.4)
1.000
1.000
GG
Yes
423 (40.4)
264 (24.5)
3.133 (2.472-3.970)
2.665 (2.054-3.458)
GA+AA
No
131 (12.5)
245 (22.7)
1.045 (0.792-1.381)
1.085 (0.801-1.470)
GA+AA
Yes
315 (30.1)
220 (20.4)
2.800 (2.182-3.592)
2.256 (1.715-2.969)
rs3740535 × passive smoking
ORmultiply (95% CI)
1.678 (1.376-2.046)
1.424 (1.142-1.774)
rs3740535 with drink alcohol
GG
No
392 (37.4)
450 (41.7)
1.000
1.000
GG
Yes
210 (20.0)
164 (15.2)
1.470 (1.150-1.878)
0.966 (0.725-1.288)
GA+AA
No
292 (27.9)
320 (29.7)
1.048 (0.850-1.290)
1.003 (0.792-1.270)
GA+AA
Yes
154 (14.7)
145 (13.4)
1.219 (0.936-1.588)
0.787 (0.578-1.071)
rs3740535 × drink alcohol
ORmultiply (95% CI)
1.110 (0.869-1.417)
0.794 (0.599-1.053)
rs3740535 with history of lung disease
GG
No
528 (50.4)
564 (52.3)
1.000
1.000
GG
Yes
74 (7.1)
50 (4.6)
1.581 (1.083-2.307)
1.593 (1.034-2.453)
GA+AA
No
395 (37.7)
426 (39.5)
0.990 (0.826-1.187)
0.966 (0.787-1.186)
GA+AA
Yes
51 (4.9)
39 (3.6)
1.397 (0.906-2.155)
1.129 (0.693-1.837)
rs3740535× history of lung disease
ORmultiply (95% CI)
1.364 (0.891-2.088)
1.110 (0.688-1.790)
rs3740535 with family history of cancer
GG
No
485 (46.3)
524 (48.6)
1.000
1.000
GG
Yes
117 (11.2)
90 (8.3)
1.405 (1.039-1.898)
1.388 (0.989-1.949)
GA+AA
No
352 (33.6)
395 (36.6)
0.963 (0.797-1.164)
0.908 (0.733-1.124)
GA+AA
Yes
94 (9.0)
70 (6.5)
1.451 (1.040-2.024)
1.515 (1.043-2.200)
rs3740535 × family history of cancer
ORmultiply (95% CI)
1.420 (1.029-1.959)
1.517 (1.058-2.176)
rs3130932
N=1045
N=1082
rs3130932 with pollution near the place of residence
TT
No
362 (34.6)
418 (38.6)
1.000
1.000
TT
Yes
91 (8.7)
35 (3.2)
3.002 (1.984-4.544)
2.806 (1.794-4.389)
GT+GG
No
476 (45.6)
578 (53.4)
0.951 (0.790-1.145)
0.937 (0.762-1.153)
GT+GG
Yes
116 (11.1)
51 (4.7)
2.626 (1.836-3.757)
2.245 (1.513-3.331)
rs3130932 × pollution near the place of residence
ORmultiply (95% CI)
2.524 (1.795-3.550)
2.166 (1.489-3.151)
rs3130932 with house type
TT
No
149 (14.3)
75 (6.9)
1.000
1.000
TT
Yes
304 (29.1)
378 (34.9)
0.405 (0.295-0.555)
0.584 (0.408-0.836)
GT+GG
No
207 (19.8)
103 (9.5)
1.012 (0.703-1.456)
1.099 (0.737-1.638)
GT+GG
Yes
385 (36.8)
526 (48.6)
0.368 (0.271-0.501)
0.509 (0.359-0.723)
rs3130932 × house type
ORmultiply (95% CI)
0.617 (0.519-0.733)
0.701 (0.575-0.854)
rs3130932 with ventilation situation
TT
No
14 (1.3)
7 (0.6)
1.000
1.000
TT
Yes
439 (42.0)
446 (41.2)
0.492 (0.197-1.231)
0.516 (0.190-1.402)
GT+GG
No
24 (2.3)
8 (0.7)
1.500 (0.447-5.029)
1.086 (0.292-4.045)
GT+GG
Yes
568 (54.4)
621 (57.4)
0.457 (0.183-1.141)
0.473 (0.174-1.282)
rs3130932 × ventilation situation
ORmultiply (95% CI)
0.884 (0.745-1.049)
1.638 (1.149-2.334)
rs3130932 with kitchen ventilator
TT
No
204 (19.5)
147 (13.6)
1.000
1.000
TT
Yes
249 (23.8)
306 (28.3)
0.586 (0.448-0.768)
1.036 (0.752-1.427)
GT+GG
No
246 (23.5)
179 (16.5)
0.990 (0.744-1.319)
1.025 (0.744-1.411)
GT+GG
Yes
346 (33.1)
450 (41.6)
0.554 (0.430-0.714)
0.894 (0.662-1.207)
rs3130932 × kitchen ventilator
ORmultiply (95% CI)
0.695 (0.583-0.830)
0.872 (0.711-1.070)
rs3130932 with COF
TT
No
85 (8.1)
150 (13.9)
1.000
1.000
TT
Yes
368 (35.2)
303 (28.0)
2.143 (1.578-2.912)
1.744 (1.238-2.458)
GT+GG
No
96 (9.2)
191 (17.7)
0.887 (0.618-1.274)
0.849 (0.568-1.268)
GT+GG
Yes
496 (47.5)
438 (40.5)
1.998 (1.487-2.685)
1.643 (1.180-2.287)
rs3130932 × COF
ORmultiply (95% CI)
1.328 (1.119-1.577)
0.951 (0.895-1.011)
rs3130932 with smoking
TT
No
170 (16.3)
268 (24.8)
1.000
1.000
TT
Yes
283 (27.1)
185 (17.1)
2.412 (1.847-3.149)
2.016 (1.477-2.752)
GT+GG
No
223 (21.3)
370 (34.2)
0.950 (0.737-1.225)
0.929 (0.702-1.229)
GT+GG
Yes
369 (35.3)
259 (23.9)
2.246 (1.750-2.882)
1.835 (1.372-2.455)
rs3130932 × smoking
ORmultiply (95% CI)
1.735 (1.436-2.095)
1.421 (1.145-1.764)
rs3130932 with passive smoking
TT
No
133 (12.7)
260 (24.0)
1.000
1.000
TT
Yes
320 (30.6)
193 (17.8)
3.241 (2.467-4.267)
2.598 (1.921-3.513)
GT+GG
No
178 (17.0)
340 (31.4)
1.023 (0.776-1.350)
1.006 (0.744-1.361)
GT+GG
Yes
414 (39.6)
289 (26.7)
2.800 (2.165-3.622)
2.237 (1.685-2.970)
rs3130932 × passive smoking
ORmultiply (95% CI)
1.800 (1.499-2.162)
1.548 (1.263-1.897)
rs3130932 with drink alcohol
TT
No
296 (28.3)
325 (30.0)
1.000
1.000
TT
Yes
157 (15.0)
128 (11.8)
1.347 (1.016-1.785)
0.861 (0.621-1.194)
GT+GG
No
385 (36.8)
449 (41.5)
0.941 (0.765-1.159)
0.910 (0.719-1.152)
GT+GG
Yes
207 (19.8)
180 (16.6)
1.263 (0.979-1.628)
0.808 (0.598-1.091)
rs3130932 × drink alcohol
ORmultiply (95% CI)
1.238 (0.993-1.544)
0.872 (0.674-1.129)
rs3130932 with history of lung disease
TT
No
398 (38.1)
417 (38.5)
1.000
1.000
TT
Yes
55 (5.3)
36 (3.3)
1.601 (1.029-2.491)
1.495 (0.909-2.460)
GT+GG
No
524 (50.1)
575 (53.1)
0.955 (0.796-1.145)
0.934 (0.761-1.145)
GT+GG
Yes
68 (6.5)
54 (5.0)
1.319 (0.900-1.935)
1.185 (0.762-1.841)
rs3130932 × history of lung disease
ORmultiply (95% CI)
1.412 (1.065-1.871)
1.205 (0.789-1.843)
rs3130932 with family history of cancer
TT
No
369 (35.3)
387 (35.8)
1.000
1.000
TT
Yes
84 (8.0)
66 (6.1)
1.335 (0.938-1.899)
1.267 (0.855-1.878)
GT+GG
No
467 (44.7)
534 (49.4)
0.917 (0.759-1.108)
0.877 (0.708-1.085)
GT+GG
Yes
125 (12.0)
95 (8.8)
1.380 (1.020-1.867)
1.462 (1.037-2.061)
rs3130932 × family history of cancer
ORmultiply (95% CI)
1.412 (1.065-1.871)
1.537 (1.117-2.116)
#By the degree of education, marital status, BMI, pollution near the place of residence, house type, ventilation situation, COF, kitchen ventilator, smoking, passive smoking, drink alcohol, history of lung disease, and family history of cancer adjusted. OR and its interval shown in italic font to represent the P<0.05.Table 6
Joint and multiplication interaction between gene recessive model and environmental factors.
Genotype
Environment
Case (%)
Control (%)
OR (95% CI)
aOR (95% CI)#
rs13409
N=1022
N=1053
rs13409 with pollution near the place of residence
CT+CC
No
736 (72.0)
866 (82.2)
1.000
1.000
CT+CC
Yes
165 (16.1)
78 (7.4)
2.489 (1.869-3.315)
2.224 (1.624-3.046)
TT
No
88 (8.6)
103 (9.8)
1.005 (0.744-1.358)
0.909 (0.649-1.272)
TT
Yes
33 (3.2)
6 (0.6)
6.471 (2.697-15.530)
6.308 (2.516-15.815)
rs13409 × pollution near the place of residence
ORmultiply (95% CI)
5.823 (2.429-13.956)
5.766 (2.302-14.444)
rs13409 with house type
CT+CC
No
303 (29.6)
156 (14.8)
1.000
1.000
CT+CC
Yes
598 (58.5)
788 (74.8)
0.402 (0.302-0.535)
0.448 (0.328-0.613)
TT
No
45 (4.4)
17 (1.6)
2.600 (1.046-6.463)
2.935 (1.131-7.617)
TT
Yes
76 (7.4)
92 (8.7)
0.404 (0.273-0.598)
0.401 (0.261-0.617)
rs13409 × house type
ORmultiply (95% CI)
1.009 (0.866-1.175)
0.846 (0.595-1.203)
rs13409 with ventilation situation
CT+CC
No
31 (3.0)
13 (1.2)
1.000
1.000
CT+CC
Yes
870 (85.1)
931 (88.4)
0.392 (0.204-0.754)
0.509 (0.248-1.045)
TT
No
5 (0.5)
2 (0.2)
1.048 (0.180-6.112)
1.311 (0.194-8.848)
TT
Yes
116 (11.4)
107 (10.2)
0.455 (0.226-0.914)
0.544 (0.252-1.175)
rs13409 × ventilation situation
ORmultiply (95% CI)
1.132 (0.857-1.495)
2.274 (1.095-4.724)
rs13409 with kitchen ventilator
CT+CC
No
381 (37.3)
275 (26.1)
1.000
1.000
CT+CC
Yes
520 (50.9)
669 (63.5)
0.561 (0.463-0.680)
0.913 (0.718-1.160)
TT
No
58 (5.7)
40 (3.8)
1.047 (0.680-1.612)
0.934 (0.577-1.512)
TT
Yes
63 (6.2)
69 (6.6)
0.659 (0.453-0.959)
1.046 (0.680-1.608)
rs13409 × kitchen ventilator
ORmultiply (95% CI)
0.937 (0.658-1.333)
1.117 (0.752-1.658)
rs13409 with COF
CT+CC
No
149 (14.6)
311 (29.5)
1.000
1.000
CT+CC
Yes
752 (73.6)
633 (60.1)
2.480 (1.986-3.096)
2.177 (1.696-2.794)
TT
No
23 (2.3)
24 (2.3)
2.000 (1.093-3.661)
2.403 (1.236-4.673)
TT
Yes
98 (9.6)
85 (8.1)
2.406 (1.696-3.415)
1.864 (1.260-2.759)
rs13409 × COF
ORmultiply (95% CI)
1.208 (0.891-1.637)
1.015 (0.916-1.124)
rs13409 with smoking
CT+CC
No
351 (34.3)
561 (53.3)
1.000
1.000
CT+CC
Yes
550 (53.8)
383 (36.4)
2.295 (1.905-2.766)
1.954 (1.559-2.450)
TT
No
40 (3.9)
64 (6.1)
0.999 (0.658-1.516)
0.935 (0.592-1.477)
TT
Yes
81 (7.9)
45 (4.3)
2.877 (1.952-4.241)
2.287 (1.468-3.563)
rs13409 × smoking
ORmultiply (95% CI)
1.928 (1.325-2.086)
1.515 (0.995-2.307)
rs13409 with passive smoking
CT+CC
No
271 (26.5)
528 (50.1)
1.000
1.000
CT+CC
Yes
630 (61.6)
416 (39.5)
2.951 (2.436-3.574)
2.403 (1.945-2.969)
TT
No
36 (3.5)
56 (5.3)
1.253 (0.804-1.925)
1.111 (0.683-1.807)
TT
Yes
85 (8.3)
53 (5.0)
3.125 (2.152-4.537)
2.445 (1.622-3.684)
rs13409 × passive smoking
ORmultiply (95% CI)
1.712 (1.201-2.440)
1.475 (0.997-2.181)
rs13409 with drink alcohol
CT+CC
No
598 (58.5)
675 (64.1)
1.000
1.000
CT+CC
Yes
303 (29.6)
269 (25.5)
1.271 (1.043-1.549)
0.829 (0.652-1.052)
TT
No
73 (7.1)
75 (7.1)
1.099 (0.782-1.544)
0.983 (0.669-1.444)
TT
Yes
48 (4.7)
34 (3.2)
1.594 (1.013-2.506)
0.992 (0.594-1.659)
rs13409 × drink alcohol
ORmultiply (95% CI)
1.477 (0.944-2.312)
1.070 (0.647-1.768)
rs13409 with history of lung disease
CT+CC
No
793 (77.6)
859 (81.6)
1.000
1.000
CT+CC
Yes
108 (10.6)
85 (8.1)
1.376 (1.019-1.858)
1.289 (0.915-1.816)
TT
No
101 (9.9)
105 (10.0)
1.042 (0.780-1.392)
0.944 (0.682-1.308)
TT
Yes
20 (2.0)
4 (0.4)
5.416 (1.843-15.914)
4.406 (1.394-13.930)
rs13409 × history of lung disease
ORmultiply (95% CI)
5.235 (1.783-15.368)
4.313 (1.366-13.620)
rs13409 with family history of cancer
CT+CC
No
714 (69.9)
805 (76.4)
1.000
1.000
CT+CC
Yes
187 (18.3)
139 (13.2)
1.517 (1.191-1.931)
1.522 (1.160-1.998)
TT
No
101 (9.9)
91 (8.6)
1.251 (0.926-1.690)
1.101 (0.784-1.546)
TT
Yes
20 (2.0)
18 (1.7)
1.253 (0.657-2.387)
1.296 (0.632-2.661)
rs13409 × family history of cancer
ORmultiply (95% CI)
1.148 (0.604-2.182)
1.197 (0.584-2.453)
rs6815391
N=1020
N=1033
rs6815391 with pollution near the place of residence
TT+CT
No
733 (71.9)
832 (80.5)
1.000
1.000
TT+CT
Yes
182 (17.8)
75 (7.3)
2.754 (2.068-3.669)
2.474 (1.812-3.377)
CC
No
88 (8.6)
115 (11.1)
0.869 (0.647-1.166)
1.001 (0.721-1.389)
CC
Yes
17 (1.7)
11 (1.1)
1.754 (0.816-3.769)
1.963 (0.855-4.505)
rs6815391 × pollution near the place of residence
ORmultiply (95% CI)
1.575 (0.734-3.379)
1.754 (0.764-4.026)
rs6815391 with house type
TT+CT
No
302 (29.6)
144 (13.9)
1.000
1.000
TT+CT
Yes
613 (60.1)
763 (73.9)
0.383 (0.306-0.480)
0.508 (0.391-0.661)
CC
No
32 (3.1)
21 (2.0)
0.727 (0.405-1.304)
0.844 (0.445-1.602)
CC
Yes
73 (7.2)
105 (10.2)
0.332 (0.232-0.474)
0.517 (0.344-0.777)
rs6815391 × house type
ORmultiply (95% CI)
0.681 (0.499-0.931)
0.875 (0.616-1.243)
rs6815391 with ventilation situation
TT+CT
No
36 (3.5)
13 (1.3)
1.000
1.000
TT+CT
Yes
879 (86.2)
894 (86.5)
0.355 (0.187-0.674)
0.412 (0.204-0.831)
CC
No
2 (0.2)
2 (0.2)
0.361 (0.046-2.838)
0.193 (0.021-1.757)
CC
Yes
103 (10.1)
124 (12.0)
0.300 (0.151-0.596)
0.410 (0.193-0.869)
rs6815391 × ventilation situation
ORmultiply (95% CI)
0.823 (0.624-1.086)
1.031 (0.466-2.281)
rs6815391 with kitchen ventilator
TT+CT
No
402 (39.4)
279 (27.0)
1.000
1.000
TT+CT
Yes
513 (50.3)
628 (60.8)
0.567 (0.468-0.687)
0.910 (0.717-1.155)
CC
No
33 (3.2)
28 (2.7)
0.818 (0.483-1.384)
0.860 (0.478-1.547)
CC
Yes
72 (7.1)
98 (9.5)
0.510 (0.363-0.717)
0.927 (0.627-1.372)
rs6815391 × kitchen ventilator
ORmultiply (95% CI)
0.725 (0.528-0.995)
0.994 (0.698-1.415)
rs6815391 with COF
TT+CT
No
150 (14.7)
290 (28.1)
1.000
1.000
TT+CT
Yes
765 (75.0)
617 (59.7)
2.397 (1.916-2.998)
1.999 (1.554-2.571)
CC
No
25 (2.5)
47 (4.5)
1.028 (0.609-1.736)
1.080 (0.614-1.900)
CC
Yes
80 (7.8)
79 (7.6)
1.958 (1.355-2.829)
1.855 (1.232-2.791)
rs6815391 × COF
ORmultiply (95% CI)
1.028 (0.744-1.421)
0.960 (0.872-1.057)
rs6815391 with smoking
TT+CT
No
349 (34.2)
536 (51.9)
1.000
1.000
TT+CT
Yes
566 (55.5)
371 (35.9)
2.343 (1.942-2.827)
2.008 (1.596-2.525)
CC
No
39 (3.8)
82 (7.9)
0.730 (0.487-1.094)
0.858 (0.555-1.328)
CC
Yes
66 (6.5)
44 (4.3)
2.304 (1.537-3.453)
2.221 (1.417-3.482)
rs6815391 × smoking
ORmultiply (95% CI)
1.555 (1.051-2.301)
1.531 (0.994-2.359)
rs6815391 with passive smoking
TT+CT
No
273 (26.8)
499 (48.3)
1.000
1.000
TT+CT
Yes
642 (62.9)
408 (39.5)
2.876 (2.372-3.488)
2.253 (1.822-2.786)
CC
No
38 (3.7)
75 (7.3)
0.926 (0.610-1.406)
0.895 (0.569-1.409)
CC
Yes
67 (6.6)
51 (4.9)
2.401 (1.621-3.557)
2.356 (1.530-3.629)
rs6815391 × passive smoking
ORmultiply (95% CI)
1.354 (0.930-1.970)
1.516 (1.000-2.300)
rs6815391 with drink alcohol
TT+CT
No
603 (59.1)
658 (63.7)
1.000
1.000
TT+CT
Yes
312 (30.6)
249 (24.1)
1.367 (1.120-1.670)
0.874 (0.686-1.112)
CC
No
71 (7.0)
91 (8.8)
0.851 (0.612-1.184)
0.981 (0.678-1.420)
CC
Yes
34 (3.3)
35 (3.4)
1.060 (0.653-1.721)
0.833 (0.484-1.435)
rs6815391 × drink alcohol
ORmultiply (95% CI)
0.983 (0.608-1.589)
0.877 (0.515-1.496)
rs6815391 with history of lung disease
TT+CT
No
800 (78.4)
841 (81.4)
1.000
1.000
TT+CT
Yes
115 (11.3)
66 (6.4)
1.832 (1.333-2.517)
1.702 (1.186-2.445)
CC
No
96 (9.4)
115 (11.1)
0.878 (0.658-1.170)
1.032 (0.748-1.424)
CC
Yes
9 (0.9)
11 (1.1)
0.860 (0.355-2.087)
0.906 (0.340-2.416)
rs6815391 × history of lung disease
ORmultiply (95% CI)
0.827 (0.341-2.004)
0.853 (0.320-2.277)
rs6815391 with family history of cancer
TT+CT
No
736 (72.2)
768 (74.3)
1.000
1.000
TT+CT
Yes
179 (17.5)
139 (13.5)
1.344 (1.053-1.714)
1.409 (1.072-1.852)
CC
No
82 (8.0)
108 (10.5)
0.792 (0.584-1.074)
0.940 (0.670-1.319)
CC
Yes
23 (2.3)
18 (1.7)
1.333 (0.714-2.491)
1.614 (0.795-3.274)
rs6815391 × family history of cancer
ORmultiply (95% CI)
1.301 (0.698-2.425)
1.535 (0.758-3.106)
rs3740535
N=1048
N=1079
rs3740535 with pollution near the place of residence
GA+GG
No
779 (74.3)
934 (86.6)
1.000
1.000
GA+GG
Yes
196 (18.7)
81 (7.5)
2.901 (2.202-3.823)
2.669 (1.976-3.605)
AA
No
61 (5.8)
58 (5.4)
1.261 (0.869-1.829)
1.188 (0.784-1.800)
AA
Yes
12 (1.1)
6 (0.6)
2.398 (0.896-6.419)
1.624 (0.537-4.911)
rs3740535 × pollution near the place of residence
ORmultiply (95% CI)
2.071 (0.775-5.540)
1.419 (0.470-4.289)
rs3740535 with house type
GA+GG
No
322 (30.7)
166 (15.4)
1.000
1.000
GA+GG
Yes
653 (62.3)
849 (78.7)
0.397 (0.320-0.491)
0.516 (0.403-0.661)
AA
No
33 (3.1)
12 (1.1)
1.418 (0.713-2.817)
1.232 (0.578-2.624)
AA
Yes
40 (3.8)
52 (4.8)
0.397 (0.252-0.624)
0.546 (0.331-0.898)
rs3740535 × house type
ORmultiply (95% CI)
0.784 (0.514-1.194)
0.875 (0.548-1.395)
rs3740535 with ventilation situation
GA+GG
No
37 (3.5)
13 (1.2)
1.000
1.000
GA+GG
Yes
938 (89.5)
1002 (92.9)
0.329 (0.174-0.623)
0.384 (0.191-0.773)
AA
No
2 (0.2)
3 (0.3)
0.234 (0.035-1.562)
0.109 (0.013-0.925)
AA
Yes
71 (6.8)
61 (5.7)
0.409 (0.199-0.839)
0.450 (0.204-0.992)
rs3740535 × ventilation situation
ORmultiply (95% CI)
1.213 (0.852-1.727)
1.476 (0.475-4.529)
rs3740535 with kitchen ventilator
GA+GG
No
400 (38.2)
305 (28.3)
1.000
1.000
GA+GG
Yes
575 (54.9)
710 (65.8)
0.618 (0.513-0.743)
1.013 (0.804-1.275)
AA
No
50 (4.8)
19 (1.8)
2.007 (1.159-3.474)
2.027 (1.170-3.730)
AA
Yes
23 (2.2)
45 (4.2)
0.390 (0.231-0.658)
0.656 (0.366-1.178)
rs3740535 × kitchen ventilator
ORmultiply (95% CI)
0.516 (0.310-0.858)
0.641 (0.365-1.123)
rs3740535 with COF
GA+GG
No
170 (16.2)
321 (29.7)
1.000
1.000
GA+GG
Yes
805 (76.8)
694 (64.3)
2.190 (1.772-2.707)
1.851 (1.458-2.349)
AA
No
10 (1.0)
21 (1.9)
0.899 (0.414-1.953)
0.887 (0.386-2.039)
AA
Yes
63 (6.0)
43 (4.0)
2.766 (1.800-4.253)
2.163 (1.329-3.521)
rs3740535 × COF
ORmultiply (95% CI)
1.541 (1.036-2.293)
1.017 (0.895-1.155)
rs3740535 with smoking
GA+GG
No
376 (35.9)
595 (55.1)
1.000
1.000
GA+GG
Yes
599 (57.2)
420 (38.9)
2.257 (1.886-2.701)
1.900 (1.525-2.367)
AA
No
24 (2.3)
40 (3.7)
0.949 (0.563-1.601)
0.903 (0.510-1.598)
AA
Yes
49 (4.7)
24 (2.2)
3.231 (1.950-5.354)
2.539 (1.442-4.471)
rs3740535 × smoking
ORmultiply (95% CI)
2.156 (1.313-3.540)
1.781 (1.024-3.100)
rs3740535 with passive smoking
GA+GG
No
283 (27.0)
557 (51.6)
1.000
1.000
GA+GG
Yes
692 (66.0)
458 (42.4)
2.974 (2.470-3.580)
2.406 (1.961-2.952)
AA
No
27 (2.6)
38 (3.5)
1.398 (0.837-2.337)
1.133 (0.641-2.005)
AA
Yes
46 (4.4)
26 (2.4)
3.48 2 (2.108-5.751)
2.591 (1.495-4.489)
rs3740535 × passive smoking
ORmultiply (95% CI)
1.859 (1.141-3.031)
1.560 (0.909-2.679)
rs3740535 with drink alcohol
GA+GG
No
636 (60.7)
719 (66.6)
1.000
1.000
GA+GG
Yes
339 (32.3)
296 (27.4)
1.295 (1.072-1.564)
0.847 (0.673-1.064)
AA
No
48 (4.6)
51 (4.7)
1.064 (0.707-1.601)
0.906 (0.569-1.443)
AA
Yes
25 (2.4)
13 (1.2)
2.174 (1.103-4.285)
1.566 (0.731-3.355)
rs3740535 × drink alcohol
ORmultiply (95% CI)
2.004 (1.020-3.938)
1.683 (0.791-3.577)
rs3740535 with history of lung disease
GA+GG
No
859 (82.0)
935 (86.7)
1.000
1.000
GA+GG
Yes
116 (11.1)
80 (7.4)
1.578 (1.170-2.129)
1.467 (1.043-2.064)
AA
No
64 (6.1)
55 (5.1)
1.267 (0.873-1.838)
1.199 (0.786-1.829)
AA
Yes
9 (0.9)
9 (0.8)
1.088 (0.430-2.755)
0.920 (0.320-2.644)
rs3740535 × history of lung disease
ORmultiply (95% CI)
1.030 (0.407-2.605)
0.880 (0.306-2.529)
rs3740535 with family history of cancer
GA+GG
No
783 (74.7)
866 (80.3)
1.000
1.000
GA+GG
Yes
192 (18.3)
149 (13.8)
1.425 (1.127-1.802)
1.551 (1.191-2.019)
AA
No
54 (5.2)
53 (4.9)
1.127 (0.762-1.666)
1.209 (0.779-1.874)
AA
Yes
19 (1.8)
11 (1.0)
1.910 (0.903-4.040)
1.189 (0.517-2.738)
rs3740535 × family history of cancer
ORmultiply (95% CI)
1.793 (0.849-3.786)
1.094 (0.476-2.510)
rs3130932
N=1045
N=1082
rs3130932 with pollution near the place of residence
GT+TT
No
728 (69.7)
867 (80.1)
1.000
1.000
GT+TT
Yes
185 (17.7)
80 (7.4)
2.754 (2.081-3.645)
2.418 (1.780-3.284)
GG
No
110 (10.5)
129 (11.9)
1.016 (0.773-1.334)
1.028 (0.757-1.396)
GG
Yes
22 (2.1)
6 (0.6)
4.367 (1.761-10.827)
4.881 (1.849-12.885)
rs3130932 × pollution near the place of residence
ORmultiply (95% CI)
3.857 (1.557-9.550)
4.354 (1.649-11.495)
rs3130932 with house type
GT+TT
No
302 (28.9)
153 (14.1)
1.000
1.000
GT+TT
Yes
611 (58.5)
794 (73.4)
0.390 (0.312-0.486)
0.542 (0.419-0.701)
GG
No
54 (5.2)
25 (2.3)
1.094 (0.656-1.827)
1.433 (0.817-2.513)
GG
Yes
78 (7.5)
110 (10.2)
0.359 (0.253-0.509)
0.535 (0.360-0.795)
rs3130932 × house type
ORmultiply (95% CI)
0.713 (0.526-0.965)
0.832 (0.591-1.171)
rs3130932 with ventilation situation
GT+TT
No
34 (3.3)
14 (1.3)
1.000
1.000
GT+TT
Yes
879 (84.1)
933 (86.2)
0.388 (0.207-0.728)
0.503 (0.253-0.998)
GG
No
4 (0.4)
1 (0.1)
1.647 (0.169-16.070)
2.456 (0.214-28.192)
GG
Yes
128 (12.2)
134 (12.4)
0.393 (0.202-0.767)
0.534 (0.257-1.110)
rs3130932 × ventilation situation
ORmultiply (95% CI)
0.988 (0.762-1.279)
1.063 (0.500-2.262)
rs3130932 with kitchen ventilator
GT+TT
No
396 (37.9)
286 (26.4)
1.000
1.000
GT+TT
Yes
517 (49.5)
661 (61.1)
0.565 (0.467-0.684)
0.926 (0.730-1.173)
GG
No
54 (5.2)
40 (3.7)
0.975 (0.630-1.508)
1.045 (0.646-1.689)
GG
Yes
78 (7.5)
95 (8.8)
0.593 (0.424-0.830)
1.040 (0.704-1.537)
rs3130932 × kitchen ventilator
ORmultiply (95% CI)
0.838 (0.613-1.145)
1.093 (0.767-1.559)
rs3130932 with COF
GT+TT
No
162 (15.5)
297 (27.4)
1.000
1.000
GT+TT
Yes
751 (71.9)
650 (60.1)
2.118 (1.703-2.635)
1.823 (1.426-2.332)
GG
No
19 (1.8)
44 (4.1)
0.792 (0.447-1.401)
1.017 (0.547-1.892)
GG
Yes
113 (10.8)
91 (8.4)
2.277 (1.627-3.185)
2.007 (1.378-2.923)
rs3130932 × COF
ORmultiply (95% CI)
1.320 (0.988-1.765)
1.013 (0.922-1.112)
rs3130932 with smoking
GT+TT
No
341 (32.6)
557 (51.5)
1.000
1.000
GT+TT
Yes
572 (54.7)
390 (36.0)
2.396 (1.988-2.886)
2.016 (1.607-2.529)
GG
No
52 (5.0)
81 (7.5)
1.049 (0.722-1.523)
1.144 (0.759-1.724)
GG
Yes
80 (7.7)
54 (5.0)
2.420 (1.671-3.505)
2.113 (1.389-3.212)
rs3130932 × smoking
ORmultiply (95% CI)
1.578 (1.105-2.253)
1.414 (0.950-2.106)
rs3130932 with passive smoking
GT+TT
No
273 (26.1)
519 (48.0)
1.000
1.000
GT+TT
Yes
640 (61.2)
428 (39.6)
2.843 (2.349-3.441)
2.296 (1.859-2.834)
GG
No
38 (3.6)
81 (7.5)
0.892 (0.591-1.347)
0.934 (0.597-1.460)
GG
Yes
94 (9.0)
54 (5.0)
3.309 (2.297-4.769)
2.835 (1.899-4.233)
rs3130932 × passive smoking
ORmultiply (95% CI)
1.882 (1.331-2.660)
1.778 (1.214-2.604)
rs3130932 with drink alcohol
GT+TT
No
592 (56.7)
678 (62.7)
1.000
1.000
GT+TT
Yes
321 (30.7)
269 (24.9)
1.367 (1.123-1.663)
0.882 (0.696-1.119)
GG
No
89 (8.5)
96 (8.9)
1.062 (0.780-1.446)
1.111 (0.785-1.573)
GG
Yes
43 (4.1)
39 (3.6)
1.263 (0.807-1.975)
0.934 (0.560-1.557)
rs3130932 × drink alcohol
ORmultiply (95% CI)
1.148 (0.738-1.786)
0.968 (0.586-1.598)
rs3130932 with history of lung disease
GT+TT
No
805 (77.0)
872 (80.6)
1.000
1.000
GT+TT
Yes
108 (10.3)
75 (6.9)
1.560 (1.144-2.126)
1.478 (1.037-2.105)
GG
No
117 (11.2)
120 (11.1)
1.056 (0.805-1.386)
1.165 (0.857-1.583)
GG
Yes
15 (1.4)
15 (1.4)
1.083 (0.526-2.230)
0.962 (0.421-2.196)
rs3130932 × history of lung disease
ORmultiply (95% CI)
1.036 (0.504-2.130)
0.914 (0.401-2.085)
rs3130932 with family history of cancer
GT+TT
No
731 (70.0)
809 (74.8)
1.000
1.000
GT+TT
Yes
182 (17.4)
138 (12.8)
1.460 (1.145-1.861)
1.484 (1.129-1.950)
GG
No
105 (10.0)
112 (10.3)
1.038 (0.781-1.379)
1.093 (0.793-1.507)
GG
Yes
27 (2.6)
23 (2.1)
1.299 (0.738-2.286)
1.632 (0.862-3.092)
rs3130932 × family history of cancer
ORmultiply (95% CI)
1.221 (0.696-2.144)
1.520 (0.805-2.873)
#By the degree of education, marital status, BMI, pollution near the place of residence, house type, ventilation situation, COF, kitchen ventilator, smoking, passive smoking, drink alcohol, history of lung disease, and family history of cancer adjusted. OR and its interval shown in italic font to represent the P<0.05.The interaction analysis for both the dominant or recessive models showed that there was no additive interaction between theREX1 rs6815391, OCT4 rs13409 or rs3130932, or CTBP2 rs3740535 polymorphisms with smoking (Table 7).Table 7
Smoking interaction with four gene loci.
RERI
AP
S
rs13409 dominant genetic model
Smoking
0.047
0.010
1.013
(-1.232-1.325)
(-0.264-0.284)
(0.712-1.441)
rs13409 recessive genetic model
Smoking
-0.638
-0.160
0.824
(-2.689-1.412)
(-0.658-0.338)
(0.478-1.422)
rs3130932 dominant genetic model
Smoking
0.303
0.074
1.108
(-0.805-1.411)
(-0.186-0.333)
(0.761-1.611)
rs3130932 recessive genetic model
Smoking
-0.107
-0.031
0.958
(-1.673-1.459)
(-0.488-0.425)
(0.516-1.776)
rs3740535 dominant genetic model
Smoking
-0.460
-0.116
0.866
(--1.662-0.742)
(-0.428-0.195)
(0.601-1.247)
rs3740535 recessive genetic model
Smoking
-1.240
-0.306
0.711
(-4.376-1.896)
(-1.036-0.423)
(0.359-1.409)
rs6815391 dominant genetic model
Smoking
-1.007
-0.247
0.754
(-2.298-0.284)
(-0.584-0.090)
(0.532-1.067)
rs6815391 recessive genetic model
Smoking
-0.657
-0.154
0.833
(-2.855-1.541)
(-656-0.349)
(0.483-1.437)


### 3.5. Multivariate Analysis

As can be observed in Tables2 and 3, REX1 rs6815391 CT+CC, OCT4 rs13409 CT+TT, and rs3130932 GT+TT were three protective genotypes, and the combination could be divided into three classes. In a collinear diagnosis, the results of multivariate analysis, marital status, BMI, COF, smoking, passive smoking, family history of cancer, history of lung disease, and lung cancer susceptibility were all independent risk factors. College or above, well ventilation, one or two protective genotypes, and no pollution near the place of residence reduced the occurrence of lung cancer (Table 8).Table 8
Multivariate analysis.
Variable
B
P
OR (OR 95% CI)
Junior and senior high school
0.125
0.442
1.133 (0.824-1.556)
College degree or above
-0.329
0.036
0.719 (0.529-0.978)
Others (marital status)
1.889
0.006
6.615 (1.704-25.678)
Single (marital status)
1.813
0.012
6.126 (1.495-25.101)
18.5<BMI<23.9
1.300
<0.001
3.674 (2.487-5.419)
BMI≥24
0.512
<0.001
1.669 (1.365-2.041)
Building (with cottage ratio)
0.409
0.436
1.505 (0.538-4.209)
Ventilation general
-0.805
0.014
0.447 (0.235-0.851)
Ventilation worse
-0.103
0.767
0.902 (0.455-1.787)
Not pollution near the place of residence
-0.843
<0.001
0.430 (0.325-0.569)
Kitchen ventilator
-0.051
0.648
0.950 (0.764-1.182)
Much fumes
1.115
<0.001
3.049 (1.674-5.556)
Some fumes
0.535
<0.001
1.708 (1.278-2.282)
Little fumes
0.630
<0.001
1.877 (1.485-2.373)
Smoking
0.653
<0.001
1.921 (1.564-2.360)
Passive smoking
0.865
<0.001
2.374 (1.959-2.878)
History of lung disease
0.333
0.037
1.394 (1.020-1.907)
Family history of cancer
0.348
0.006
1.417 (1.106-1.814)
Drink alcohol
-0.104
0.349
0.901 (0.725-1.120)
1 protected genotypes
-0.486
0.006
0.615 (0.436-0.868)
2 protected genotypes
-0.291
0.030
0.747 (0.575-0.972)
3 protected genotypes
-0.154
0.199
0.857 (0.677-1.085)
#OR and its interval shown in italic font to represent the P<0.05.


## 3.1. Demographic Characteristics and Environmental Factors

The demographic characteristics of 1121 patients and 1121 controls are listed in Table1. There were no significant differences (P>0.05) between the patient group and control group including age, gender, redecoration within 10 years, and drinking tea. However, there was a significant difference in the distribution of the educational history, marital status, BMI, pollution near the place of residence, house type, ventilation situation, COF, kitchen ventilator, smoking, passive smoking, drinking alcohol, history of lung disease, and family history of cancer between cases and controls (P<0.05) (Table 1).Table 1
Demographic characteristics of the included patients and healthy control.
Variable
Case group (%)
Control group (%)
OR (95% CI)
Age
≤52
295 (26.3)
289 (25.8)
1.000
53-59
285 (25.4)
273 (24.4)
1.012 (0.802-1.278)
60-66
272 (24.3)
274 (24.4)
0.973 (0.770-1.228)
≥67
269 (24.0)
285 (25.4)
0.925 (0.733-1.167)
Gender
Male
797 (71.1)
797 (71.1)
1.000
Female
324 (28.9)
324 (28.9)
1.000 (0.833-1.200)
Degree of education
Primary school or below
564 (50.4)
418 (37.3)
1.000
Junior and senior high school
443 (39.6)
553 (49.3)
0.594 (0.497-0.709)
College degree or above
114 (10.2)
150 (13.4)
0.563 (0.428-0.741)
Marital status
Married
1054 (94.0)
1039 (92.7)
1.000
Others
64 (5.7)
66 (5.9)
0.956 (0.671-1.362)
Single
3 (0.3)
16 (1.4)
0.185 (0.054-0.636)
BMI (kg/m2)
<18.5
124 (11.1)
51 (4.5)
1.000
18.5-23.9
694 (61.9)
613 (54.7)
0.466 (0.330-0.657)
≥24
303 (27.0)
457 (40.8)
0.273 (0.191-0.390)
Pollution near the place of residence
Not
900 (80.3)
1026 (91.5)
1.000
Exist
221 (19.7)
95 (8.5)
2.652 (2.052-3.428)
House type
Bungalow
377 (33.6)
182 (16.2)
1.000
Building
734 (65.5)
931 (83.1)
0.381 (0.311-0.466)
Others
10 (0.9)
8 (0.7)
0.603 (0.234-1.555)
Ventilation situation
Well
859 (76.6)
990 (88.3)
1.000
General
223 (19.9)
115 (10.3)
2.235 (1.753-2.849)
Worse
39 (3.5)
16 (1.4)
2.809 (1.559-5.063)
Cooking oil fume (COF)
No
190 (16.9)
350 (31.2)
1.000
Little
613 (54.7)
544 (48.5)
2.076 (1.681-2.563)
Some
269 (24.0)
205 (18.3)
2.417 (1.876-3.114)
Much
49 (4.4)
22 (2.0)
4.103 (2.407-6.992)
Kitchen ventilator
No
480 (42.8)
337 (30.1)
1.000
Yes
641 (57.2)
784 (69.9)
0.574 (0.482-0.683)
Decoration within 10 years
No
674 (60.1)
692 (61.7)
1.000
Yes
447 (39.9)
429 (38.3)
1.070 (0.903-1.268)
Smoking
No
425 (37.9)
659 (58.8)
1.000
Yes
696 (62.1)
462 (41.2)
2.336 (1.972-2.767)
Passive smoking
No
335 (29.9)
621 (55.4)
1.000
Yes
786 (70.1)
500 (44.6)
2.914 (2.449-3.467)
Drink alcohol
No
733 (65.4)
805 (71.8)
1.000
Yes
388 (34.6)
316 (28.2)
1.348 (1.127-1.613)
Drink tea
No
566 (50.5)
537 (47.9)
1.000
Yes
555 (49.5)
584 (52.1)
0.902 (0.764-1.064)
History of lung disease
No
983 (87.7)
1025 (91.4)
1.000
Yes
138 (12.3)
96 (8.6)
1.499 (1.139-1.973)
Family history of cancer
No
900 (80.3)
950 (84.7)
1.000
Yes
221 (19.7)
171 (15.3)
1.364 (1.095-1.699)
BMI = weight (kg)/height2 (m2).


## 3.2. The Relationship between the Four SNPs and Susceptibility to Lung Cancer

The results of unconditional logistic regression analysis showed that there was no association betweenREX1 rs6815391, OCT4 rs3130932, or CTBP2 rs3740535 polymorphisms with susceptibility to lung cancer after adjusting for lung cancer-related factors, whether in co-dominant or dominant, recessive, additive, or genetic models. Only OCT4 rs13409 was associated with lung cancer occurrence. In the co-dominant model, the lung cancer risk of the OCT4 rs13409 CT genotype carriers was 0.731-fold that of the CC genotype carriers (95% CI: 0.595-0.899, P<0.05); in the dominant model, the risk of lung cancer in the CT+TT genotype carriers was 0.765-fold that of the CC carriers (95% CI: 0.629-0.930, P<0.05) (Tables 2 and 3).Table 2
Association of rs13409 SNP with susceptibility to lung cancer.
Genotyping
Case (%)
Control (%)
OR (95% CI)
a(OR (95% CI)#
N=1022
N=1053
Codominant
CC
512 (50.1)
466 (44.3)
1.000
1.000
CT
389 (38.1)
478 (45.4)
0.741 (0.617-0.890)
0.731 (0.595-0.899)
TT
121 (11.8)
109 (10.3)
1.010 (0.758-1.347)
0.908 (0.657-1.257)
Dominant
CC
512 (50.1)
466 (44.3)
1.000
1.000
CT+TT
510 (49.9)
587 (55.7)
0.791 (0.665-0.940)
0.765 (0.629-0.930)
Recessive
CC+CT
901 (88.2)
944 (89.7)
1.000
1.000
TT
121 (11.8)
109 (10.3)
1.163 (0.884-1.530)
1.054 (0.774-1.436)
Additive
0.908 (0.799-1.032)
0.873 (0.755-1.009)
#By the degree of education, marital status, BMI, pollution near the place of residence, house type, ventilation situation, COF, kitchen ventilator, smoking, passive smoking, drink alcohol, history of lung disease, and family history of cancer adjusted. OR and its interval shown in italic font to represent P<0.05.Table 3
Association of another three SNPs with susceptibility to lung cancer.
Classification
Case (%)
Control (%)
OR (95% CI)
aOR (95% CI)#
N=1020
N=1033
rs6815391PHWE=0.099
Codominant
TT
477 (46.8)
472 (45.7)
1.000
1.000
CT
438 (42.9)
435 (42.1)
0.996 (0.829-1.197)
0.901 (0.732-1.109)
CC
105 (10.3)
126 (12.2)
0.825 (0.618-1.100)
0.925 (0.670-1.279)
Dominant
TT
477 (46.8)
472 (45.7)
1.000
1.000
CT+CC
543 (53.2)
561 (54.3)
0.958 (0.805-1.139)
0.906 (0.745-1.102)
Recessive
TT+CT
915 (89.7)
907 (87.8)
1.000
1.000
CC
105 (10.3)
126 (12.2)
0.826 (0.628-1.087)
0.973 (0.715-1.323)
Additive
0.936 (0.823-1.065)
0.942 (0.814-1.089)
rs3740535PHWE=0.890
Codominant
GG
602 (57.4)
614 (56.9)
1.000
1.000
AG
373 (35.6)
401 (37.1)
0.949 (0.792-1.136)
0.916 (0.747-1.124)
AA
73 (7.0)
64 (6.0)
1.163 (0.817-1.657)
1.067 (0.714-1.594)
Dominant
GG
602 (57.4)
614 (56.9)
1.000
1.000
AG+AA
446 (42.6)
465 (43.1)
0.978 (0.824-1.162)
0.937 (0.772-1.139)
Recessive
AG+GG
975 (93.0)
1015 (94.0)
1.000
1.000
AA
73 (7.0)
64 (6.0)
1.187 (0.839-1.680)
1.103 (0.744-1.636)
Additive
1.013 (0.882-1.163)
0.974 (0.833-1.139)
rs3130932PHWE=0.986
Codominant
TT
453 (43.4)
453 (41.8)
1.000
1.000
GT
460 (44.0)
494 (45.7)
0.931 (0.776-1.117)
0.890 (0.725-1.093)
GG
132 (12.6)
135 (12.5)
0.978 (0.744-1.285)
1.031 (0.757-1.404)
Dominant
TT
453 (43.4)
453 (41.8)
1.000
1.000
GT+GG
592 (56.6)
629 (58.2)
0.941 (0.793-1.118)
0.919 (0.757-1.116)
Recessive
GT+TT
913 (87.4)
947 (87.5)
1.000
1.000
GG
132 (12.6)
135 (12.5)
1.014 (0.785-1.311)
1.095 (0.819-1.463)
Additive
0.972 (0.857-1.101)
0.977 (0.848-1.125)
#By the degree of education, marital status, BMI, pollution near the place of residence, house type, ventilation situation, COF, kitchen ventilator, smoking, passive smoking, drink alcohol, history of lung disease, and family history of cancer adjusted.


## 3.3. Pathological Stratification Analysis

There was no significant difference betweenCTBP2 rs3740535 and REX1 rs6815391 polymorphism with lung cancer occurrence regardless of adenocarcinoma, squamous, or any type of lung cancer.For the adenocarcinoma patients withOCT4 rs13409, the risk of lung cancer in CT genotype carriers was 0.689-fold (95% CI: 0.536-0.885, P<0.05) that of the CC carriers according to the co-dominant model; the lung cancer risk of CT+TT carriers was 0.745-fold that of the CC carriers (95% CI: 0.589-0.941, P<0.05) by the dominant model. For all lung cancer types with OCT4 rs13409, a risk of lung cancer in the CT genotype carriers was 0.734-fold (95% CI: 0.610-0.884, P<0.05) that of the CC carriers according to the co-dominant model; the lung cancer risk of CT+TT carriers was 0.781-fold that of the CC carriers (95% CI: 0.656-0.930, P<0.05).Regarding squamous cell carcinoma, the risk of lung cancer inOCT4 rs3130932 GG carriers was 1.569-fold (95% CI: 1.016-2.425, P<0.05) that of the GT+TT carriers according to the recessive models (Table 4).Table 4
Association of the four SNPs of different pathological types with susceptibility to lung cancer.
Lung adenocarcinoma
Lung squamous cell carcinoma
Total
Classification
Case/control
aOR (95% CI)#
Case/control
aOR (95% CI)#
Case/control
aOR (95% CI)#
rs13409Codominant
CC
252/466
1.000
147/466
1.000
490/466
1.000
CT
177/478
0.689 (0.536-0.885)
109/478
0.756 (0.543-1.053)
369/478
0.734 (0.610-0.884)
TT
58/109
0.987 (0.672-1.450)
30/109
0.754 (0.444-1.282)
113/109
0.986 (0.736-1.320)
rs13409Dominant
CC
352/466
1.000
147/466
1.000
490/466
1.000
CT+TT
235/587
0.745 (0.589-0.941)
139/587
0.756 (0.553-1.033)
482/587
0.781 (0.656-0.930)
rs13409Recessive
CC+CT
429/944
1.000
256/944
1.000
859/944
1.000
TT
58/109
1.171 (0.811-1.692)
30/109
0.861 (0.518-1.430)
859/109
1.039 (0.862-1.506)
rs13409Additive
0.879 (0.737-1.048)
0.827 (0.653-1.047)
0.897 (0.788-1.022)
rs6815391Codominant
TT
230/472
1.000
136/472
1.000
452/472
1.000
CT
205/435
0.905 (0.705-1.161)
125/435
1.028 (0.740-1.428)
418/435
1.003 (0.833-1.209)
CC
49/126
0.836 (0.562-1.241)
26/126
0.830 (0.482-1.429)
101/126
0.837 (0.625-1.121)
rs6815391Dominant
TT
230/472
1.000
136/472
1.000
452/472
1.000
CT+CC
254/561
0.890 (0.703-1.126)
151/561
0.986 (0.722-1.348)
519/561
0.966 (0.810-1.152)
rs6815391Recessive
TT+CT
435/907
1.000
261/907
1.000
870/907
1.000
CC
49/126
0.876 (0.600-1.278)
26/126
0.819 (0.488-1.377)
101/126
0.836 (0.633-1.103)
rs6815391Additive
0.911 (0.764-1.086)
0.952 (0.752-1.204)
0.943 (0.828-1.074)
rs3740535Codominant
GG
295/614
1.000
159/614
1.000
571/614
1.000
AG
169/401
0.875 (0.683-1.123)
114/401
1.034 (0.748-1.430)
354/401
0.949 (0.791-1.140)
AA
35/64
0.968 (0.598-1.567)
19/64
1.243 (0.650-2.375)
72/64
1.210 (0.848-1.726)
rs3740535Dominant
GG
295/614
1.000
159/614
1.000
571/614
1.000
GA+AA
204/465
0.889 (0.702-1.126)
133/465
1.061 (0.778-1.447)
426/465
0.985 (0.828-1.172)
rs3740535Recessive
GA+GG
464/1015
1.000
273/1015
1.000
925/1015
1.000
AA
35/64
1.018 (0.634-1.632)
19/64
1.226 (0.650-2.314)
72/64
1.234 (0.871-1.749)
rs3740535Additive
0.930 (0.769-1.124)
1.073 (0.834-1.381)
1.024 (0.891-1.178)
rs3130932Codominant
TT
228/453
1.000
119/453
1.000
432/453
1.000
GT
213/494
0.786 (0.613-1.008)
124/494
1.030 (0.737-1.440)
438/494
0.930 (0.773-1.118)
GG
57/135
0.893 (0.611-1.307)
46/135
1.593 (0.999-2.541)
125/135
0.971 (0.736-1.280)
rs3130932Dominant
TT
228/453
1.000
119/453
1.000
432/453
1.000
GT+GG
270/629
0.807 (0.639-1.021)
170/629
1.146 (0.838-1.567)
563/629
0.939 (0.789-1.117)
rs3130932Recessive
GT+TT
441/947
1.000
243/947
1.000
870/947
1.000
GG
57/135
1.009 (0.705-1.446)
46/135
1.569 (1.016-2.425)
125/135
1.008 (0.777-1.307)
rs3130932Additive
0.894 (0.752-1.064)
1.201 (0.961-1.501)
0.969 (0.853-1.100)
#By the degree of education, marital status, BMI, pollution near the place of residence, house type, ventilation situation, COF, kitchen ventilator, smoking, passive smoking, drink alcohol, history of lung disease, and family history of cancer adjusted. OR and its interval shown in italic font to represent the P<0.05.


## 3.4. Combination and Interaction Analysis

We analyzed the interactions between the four genotypes and the environment factors including pollution near the place of residence, house type, COF, ventilation situation, kitchen ventilator, smoking, passive smoking, drink alcohol, history of lung disease, and family history of cancer (Tables5 and 6).Table 5
Joint and multiplication interaction between gene dominant model and environmental factors.
Genotype
Environment
Case (%)
Control (%)
OR (95% CI)
aOR (95% CI)#
rs13409
N=1022
N=1053
rs13409 with pollution near the place of residence
CC
No
414 (40.5)
429 (40.7)
1.000
1.000
CC
Yes
98 (9.6)
37 (3.5)
2.745 (1.837-4.101)
2.467 (1.595-3.816)
CT+TT
No
410 (40.1)
540 (51.3)
0.787 (0.653-0.948)
0.760 (0.617-0.936)
CT+TT
Yes
100 (9.8)
47 (4.5)
2.205 (1.520-3.198)
1.980 (1.316-2.977)
rs13409 × pollution near the place of residence
ORmultiply (95% CI)
2.322 (1.623-3.321)
2.119 (1.432-3.138)
rs13409 with house type
CC
No
174 (17.0)
80 (7.6)
1.000
1.000
CC
Yes
338 (33.1)
386 (36.7)
0.403 (0.298-0.545)
0.504 (0.358-0.711)
CT+TT
No
174 (17.0)
93 (8.8)
0.860 (0.597-1.240)
0.761 (0.510-1.136)
CT+TT
Yes
336 (32.9)
494 (46.9)
0.313 (0.232-0.422)
0.387 (0.276-0.542)
rs13409 × house type
ORmultiply (95% CI)
0.554 (0.464-0.662)
0.627 (0.513-0.766)
rs13409 with ventilation situation
CC
No
17 (1.7)
8 (0.8)
1.000
1.000
CC
Yes
495 (48.4)
458 (43.5)
0.509 (0.217-1.190)
0.654 (0.257-1.665)
CT+TT
No
19 (1.9)
7 (0.7)
1.277 (0.382-4.271)
1.305 (0.350-4.862)
CT+TT
Yes
491 (48.0)
580 (55.1)
0.398 (0.170-1.931)
0.497 (0.196-1.264)
rs13409 × ventilation situation
ORmultiply (95% CI)
0.754 (0.635-0.896)
0.652 (0.533-0.798)
rs13409 with kitchen ventilator
CC
No
215 (21.0)
138 (13.1)
1.000
1.000
CC
Yes
297 (29.1)
328 (31.1)
0.581 (0.446-0.758)
0.973 (0.712-1.330)
CT+TT
No
224 (21.9)
177 (16.8)
0.812 (0.607-1.086)
0.808 (0.583-1.120)
CT+TT
Yes
286 (28.0)
410 (38.9)
0.448 (0.345-0.582)
0.722 (0.530-0.984)
rs13409 × kitchen ventilator
ORmultiply (95% CI)
0.609 (0.507-0.733)
0.771 (0.623-0.954)
rs13409 with COF
CC
No
84 (8.2)
153 (14.5)
1.000
1.000
CC
Yes
428 (41.9)
313 (29.7)
2.491 (1.839-3.374)
2.101 (1.497-2.949)
CT+TT
No
88 (8.6)
182 (17.3)
0.881 (0.609-1.273)
0.855 (0.569-1.286)
CT+TT
Yes
422 (41.3)
405 (38.5)
1.898 (1.407-2.559)
1.572 (1.124-2.197)
rs13409 × COF
ORmultiply (95% CI)
1.125 (0.944-1.342)
0.890 (0.837-0.946)
rs13409 with smoking
CC
No
202 (19.8)
264 (25.1)
1.000
1.000
CC
Yes
310 (30.3)
202 (19.2)
2.006 (1.554-2.588)
1.657 (1.231-2.230)
CT+TT
No
189 (18.5)
361 (34.3)
0.684 (0.531-0.882)
0.641 (0.485-0.849)
CT+TT
Yes
321 (31.4)
226 (21.5)
1.856 (1.446-2.384)
1.496 (1.113-2.011)
rs13409 × smoking
ORmultiply (95% CI)
1.676 (1375-2.042)
1.374 (1.093-1.727)
rs13409 with passive smoking
CC
No
156 (15.3)
267 (25.4)
1.000
1.000
CC
Yes
356 (34.8)
199 (18.9)
3.062 (2.354-3.982)
2.404 (1.081-3.209)
CT+TT
No
151 (14.8)
317 (30.1)
0.815 (0.618-1.075)
0.766 (0.567-1.037)
CT+TT
Yes
359 (35.1)
270 (25.6)
2.276 (1.767-2.930)
1.837 (1.392-2.423)
rs13409 × passive smoking
ORmultiply (95% CI)
1.570 (1.300-1.897)
1.402 (1.138-1.727)
rs13409 with drink alcohol
CC
No
343 (33.6)
329 (31.2)
1.000
1.000
CC
Yes
169 (16.5)
137 (13.0)
1.183 (0.902-1.552)
0.800 (0.581-1.100)
CT+TT
No
328 (32.1)
421 (40.0)
0.747 (0.606-0.921)
0.736 (0.581-0.932)
CT+TT
Yes
182 (17.8)
166 (15.8)
1.052 (0.812-1.363)
0.665 (0.492-0.900)
rs13409 × drink alcohol
ORmultiply (95% CI)
1.158 (0.919-1.458)
0.793 (0.608-1.034)
rs13409 with history of lung disease
CC
No
452 (44.2)
422 (40.1)
1.000
1.000
CC
Yes
60 (5.9)
44 (4.2)
1.273 (0.844-1.920)
1.087 (0.680-1.737)
CT+TT
No
442 (43.2)
542 (51.5)
0.761 (0.634-0.914)
0.724 (0.589-0.889)
CT+TT
Yes
68 (6.7)
45 (4.3)
1.411 (0.946-2.103)
1.364 (0.866-2.147)
rs13409 × history of lung disease
ORmultiply (95% CI)
1.597 (1.084-2.351)
1.596 (1.028-2.477)
rs13409 with family history of cancer
CC
No
403 (39.4)
395 (37.5)
1.000
1.000
CC
Yes
109 (10.7)
71 (6.7)
1.505 (1.082-2.092)
1.495 (1.032-2.167)
CT+TT
No
412 (40.3)
501 (47.6)
0.806 (0.666-0.975)
0.769 (0.620-0.953)
CT+TT
Yes
98 (9.6)
86 (8.2)
1.117 (0.810-1.540)
1.116 (0.777-1.603)
rs13409 × family history of cancer
ORmultiply (95% CI)
1.193 (0.881-1.615)
1.218 (0.865-1.714)
rs6815391
N=1020
N=1033
rs6815391 with pollution near the place of residence
TT
No
385 (37.7)
425 (41.1)
1.000
1.000
TT
Yes
92 (9.0)
47 (4.5)
2.161 (1.481-3.152)
1.978 (1.311-2.984)
CT+CC
No
436 (42.7)
522 (50.5)
0.922 (0.764-1.112)
0.862 (0.699-1.064)
CT+CC
Yes
107 (10.5)
39 (3.8)
3.029 (2.047-4.481)
2.516 (1.647-3.845)
rs6815391 × pollution near the place of residence
ORmultiply (95% CI)
2.987 (2.048-4.357)
2.571 (1.710-3.865)
rs6815391 with house type
TT
No
140 (13.7)
73 (7.1)
1.000
1.000
TT
Yes
337 (33.0)
399 (38.6)
0.440 (0.320-0.605)
0.638 (0.444-0.915)
CT+CC
No
194 (19.0)
92 (8.9)
1.100 (0.755-1.602)
1.212 (0.802-1.832)
CT+CC
Yes
349 (34.2)
469 (45.4)
0.388 (0.283-0.532)
0.532 (0.371-0.762)
rs6815391 × house type
ORmultiply (95% CI)
0.625 (0.523-0.747)
0.679 (0.554-0.832)
rs6815391 with ventilation situation
TT
No
15 (1.5)
9 (0.9)
1.000
1.000
TT
Yes
462 (45.3)
463 (44.8)
0.599 (0.259-1.382)
0.668 (0.268-1.667)
CT+CC
No
23 (2.3)
6 (0.6)
2.300 (0.679-7.796)
1.831 (0.481-6.966)
CT+CC
Yes
520 (51.0)
555 (53.7)
0.562 (0.244-1.296)
0.599 (0.241-1.493)
rs6815391 × ventilation situation
ORmultiply (95% CI)
0.896 (0.753-1.065)
0.791 (0.645-0.969)
rs6815391 with kitchen ventilator
TT
No
209 (20.5)
143 (13.8)
1.000
1.000
TT
Yes
268 (26.3)
329 (31.8)
0.557 (0.427-0.728)
0.866 (0.632-1.187)
CT+CC
No
226 (22.2)
164 (15.9)
0.943 (0.704-1.263)
0.834 (0.602-1.156)
CT+CC
Yes
317 (31.1)
397 (38.4)
0.546 (0.422-0.708)
0.823 (0.607-1.114)
rs6815391 × kitchen ventilator
ORmultiply (95% CI)
0.722 (0.602-0.867)
0.927 (0.752-1.144)
rs6815391 with COF
TT
No
89 (8.7)
158 (15.3)
1.000
1.000
TT
Yes
388 (38.0)
314 (30.4)
2.194 (1.626-2.959)
1.824 (1.308-2.544)
CT+CC
No
86 (8.4)
179 (17.3)
0.853 (0.592-1.229)
0.812 (0.542-1.216)
CT+CC
Yes
457 (44.8)
382 (37.0)
2.124 (1.584-2.847)
1.716 (1.239-2.375)
rs6815391 × COF
ORmultiply (95% CI)
1.383 (1.159-1.651)
0.932 (0.876-0.992)
rs6815391 with smoking
TT
No
192 (18.8)
265 (25.7)
1.000
1.000
TT
Yes
285 (27.9)
207 (20.0)
1.900 (1.468-2.460)
1.644 (1.217-2.220)
CT+CC
No
196 (19.2)
353 (34.2)
0.766 (0.594-0.989)
0.727 (0.550-0.962)
CT+CC
Yes
347 (34.0)
208 (20.1)
2.303 (1.788-2.966)
1.839 (1.372-2.463)
rs6815391 × smoking
ORmultiply (95% CI)
2.045 (1.675-2.497)
1.650 (1.316-2.069)
rs6815391 with passive smoking
TT
No
138 (13.5)
258 (25.0)
1.000
1.000
TT
Yes
339 (33.2)
214 (20.7)
2.962 (2.265-3.873)
2.373 (1.771-3.180)
CT+CC
No
173 (17.0)
316 (30.6)
1.024 (0.755-1.351)
0.941 (0.695-1.274)
CT+CC
Yes
370 (36.3)
245 (23.7)
2.823 (2.172-3.670)
2.092 (1.571-2.787)
rs6815391 × passive smoking
ORmultiply (95% CI)
1.831 (1.511-2.218)
1.503 (1.216-1.857)
rs6815391 with drinking alcohol
TT
No
318 (31.2)
330 (31.9)
1.000
1.000
TT
Yes
159 (15.6)
142 (13.7)
1.162 (0.884-1.528)
0.728 (0.529-1.003)
CT+CC
No
356 (34.9)
419 (40.6)
0.882 (0.715-1.087)
0.817 (0.645-1.034)
CT+CC
Yes
187 (18.3)
142 (13.7)
1.367 (1.046-1.785)
0.831 (0.608-1.137)
rs6815391 × drink alcohol
ORmultiply (95% CI)
1.409 (1.111-1.787)
0.978 (0.743-1.287)
rs6815391 with history of lung disease
TT
No
419 (41.1)
436 (42.2)
1.000
1.000
TT
Yes
58 (5.7)
36 (3.5)
1.676 (1.083-2.595)
1.401 (0.851-2.306)
CT+CC
No
477 (46.8)
520 (50.3)
0.955 (0.795-1.146)
0.888 (0.723-1.090)
CT+CC
Yes
66 (6.5)
41 (4.0)
1.675 (1.109-2.529)
1.560 (0.977-2.490)
rs6815391× history of lung disease
ORmultiply (95% CI)
1.674 (1.122-2.496)
1.633 (1.037-2.570)
rs6815391 with family history of cancer
TT
No
385 (37.7)
400 (38.7)
1.000
1.000
TT
Yes
92 (9.0)
72 (7.0)
1.328 (0.946-1.863)
1.350 (0.923-1.975)
CT+CC
No
433 (42.5)
476 (46.1)
0.945 (0.781-1.144)
0.887 (0.715-1.101)
CT+CC
Yes
110 (10.8)
85 (8.2)
1.345 (0.980-1.844)
1.353 (0.949-1.929)
rs6815391 × family history of cancer
ORmultiply (95% CI)
1.348 (1.001-1.815)
1.396 (1.000-1.948)
rs3740535
N=1048
N=1079
rs3740535 with pollution near the place of residence
GG
No
464 (44.3)
561 (52.0)
1.000
1.000
GG
Yes
138 (13.2)
53 (4.9)
3.148 (2.241-4.422)
2.846 (1.969-4.115)
GA+AA
No
376 (35.9)
431 (39.9)
1.055 (0.877-1.269)
0.971 (0.789-1.194)
GA+AA
Yes
70 (6.7)
34 (3.2)
2.489 (1.623-3.818)
2.045 (1.276-3.278)
rs3740535 × pollution near the place of residence
ORmultiply (95% CI)
2.200 (1.447-3.344)
1.873 (1.180-2.973)
rs3740535 with house type
GG
No
204 (19.5)
85 (7.9)
1.000
1.000
GG
Yes
398 (38.0)
529 (49.0)
0.313 (0.236-0.417)
0.398 (0.288-0.548)
GA+AA
No
151 (14.4)
93 (8.6)
0.677 (0.471-0.971)
0.618 (0.415-0.920)
GA+AA
Yes
295 (28.1)
372 (34.5)
0.330 (0.246-0.444)
0.425 (0.305-0.593)
rs3740535 × house type
ORmultiply (95% CI)
0.745 (0.619-0.895)
0.845 (0.686-1.040)
rs3740535 with ventilation situation
GG
No
21 (2.0)
10 (0.9)
1.000
1.000
GG
Yes
581 (55.4)
604 (56.0)
0.458 (0.214-0.981)
0.529 (0.227-1.228)
GA+AA
No
18 (1.7)
6 (0.6)
1.429 (0.434-4.705)
1.127 (0.309-4.108)
GA+AA
Yes
428 (40.8)
459 (42.5)
0.444 (0.207-0.954)
0.490 (0.210-1.144)
rs3740535 × ventilation situation
ORmultiply (95% CI)
0.932 (0.785-1.108)
0.800 (0.652-0.980)
rs3740535 with kitchen ventilator
GG
No
249 (23.8)
162 (15.0)
1.000
1.000
GG
Yes
353 (33.7)
452 (41.9)
0.508 (0.399-0.647)
0.809 (0.608-1.076)
GA+AA
No
201 (19.2)
162 (15.0)
0.807 (0.606-1.075)
0.758 (0.550-1.045)
GA+AA
Yes
245 (23.4)
303 (28.1)
0.526 (0.406-0.682)
0.858 (0.632-1.164)
rs3740535 × kitchen ventilator
ORmultiply (95% CI)
0.781 (0.643-0.950)
1.024 (0.819-1.281)
rs3740535 with COF
GG
No
103 (9.8)
211 (19.6)
1.000
1.000
GG
Yes
499 (47.6)
403 (37.3)
2.537 (1.937-3.322)
2.217 (1.641-2.994)
GA+AA
No
77 (7.3)
131 (12.1)
1.204 (0.834-1.738)
1.272 (0.846-1.911)
GA+AA
Yes
369 (35.2)
334 (31.0)
2.263 (1.714-2.989)
1.895 (1.387-2.590)
rs3740535 × COF
ORmultiply (95% CI)
1.212 (1.012-1.453)
0.965 (0.907-1.027)
rs3740535 with smoking
GG
No
246 (23.5)
361 (33.5)
1.000
1.000
GG
Yes
356 (34.0)
253 (23.4)
2.065 (1.643-2.595)
1.729 (1.322-2.261)
GA+AA
No
154 (14.7)
274 (25.4)
0.825 (0.639-1.065)
0.806 (0.608-1.069)
GA+AA
Yes
292 (27.9)
191 (17.7)
2.243 (1.758-2.863)
1.861 (1.395-2.482)
rs3740535 × smoking
ORmultiply (95% CI)
1.796 (1.461-2.208)
1.506 (1.187-1.909)
rs3740535 with passive smoking
GG
No
179 (17.1)
350 (32.4)
1.000
1.000
GG
Yes
423 (40.4)
264 (24.5)
3.133 (2.472-3.970)
2.665 (2.054-3.458)
GA+AA
No
131 (12.5)
245 (22.7)
1.045 (0.792-1.381)
1.085 (0.801-1.470)
GA+AA
Yes
315 (30.1)
220 (20.4)
2.800 (2.182-3.592)
2.256 (1.715-2.969)
rs3740535 × passive smoking
ORmultiply (95% CI)
1.678 (1.376-2.046)
1.424 (1.142-1.774)
rs3740535 with drink alcohol
GG
No
392 (37.4)
450 (41.7)
1.000
1.000
GG
Yes
210 (20.0)
164 (15.2)
1.470 (1.150-1.878)
0.966 (0.725-1.288)
GA+AA
No
292 (27.9)
320 (29.7)
1.048 (0.850-1.290)
1.003 (0.792-1.270)
GA+AA
Yes
154 (14.7)
145 (13.4)
1.219 (0.936-1.588)
0.787 (0.578-1.071)
rs3740535 × drink alcohol
ORmultiply (95% CI)
1.110 (0.869-1.417)
0.794 (0.599-1.053)
rs3740535 with history of lung disease
GG
No
528 (50.4)
564 (52.3)
1.000
1.000
GG
Yes
74 (7.1)
50 (4.6)
1.581 (1.083-2.307)
1.593 (1.034-2.453)
GA+AA
No
395 (37.7)
426 (39.5)
0.990 (0.826-1.187)
0.966 (0.787-1.186)
GA+AA
Yes
51 (4.9)
39 (3.6)
1.397 (0.906-2.155)
1.129 (0.693-1.837)
rs3740535× history of lung disease
ORmultiply (95% CI)
1.364 (0.891-2.088)
1.110 (0.688-1.790)
rs3740535 with family history of cancer
GG
No
485 (46.3)
524 (48.6)
1.000
1.000
GG
Yes
117 (11.2)
90 (8.3)
1.405 (1.039-1.898)
1.388 (0.989-1.949)
GA+AA
No
352 (33.6)
395 (36.6)
0.963 (0.797-1.164)
0.908 (0.733-1.124)
GA+AA
Yes
94 (9.0)
70 (6.5)
1.451 (1.040-2.024)
1.515 (1.043-2.200)
rs3740535 × family history of cancer
ORmultiply (95% CI)
1.420 (1.029-1.959)
1.517 (1.058-2.176)
rs3130932
N=1045
N=1082
rs3130932 with pollution near the place of residence
TT
No
362 (34.6)
418 (38.6)
1.000
1.000
TT
Yes
91 (8.7)
35 (3.2)
3.002 (1.984-4.544)
2.806 (1.794-4.389)
GT+GG
No
476 (45.6)
578 (53.4)
0.951 (0.790-1.145)
0.937 (0.762-1.153)
GT+GG
Yes
116 (11.1)
51 (4.7)
2.626 (1.836-3.757)
2.245 (1.513-3.331)
rs3130932 × pollution near the place of residence
ORmultiply (95% CI)
2.524 (1.795-3.550)
2.166 (1.489-3.151)
rs3130932 with house type
TT
No
149 (14.3)
75 (6.9)
1.000
1.000
TT
Yes
304 (29.1)
378 (34.9)
0.405 (0.295-0.555)
0.584 (0.408-0.836)
GT+GG
No
207 (19.8)
103 (9.5)
1.012 (0.703-1.456)
1.099 (0.737-1.638)
GT+GG
Yes
385 (36.8)
526 (48.6)
0.368 (0.271-0.501)
0.509 (0.359-0.723)
rs3130932 × house type
ORmultiply (95% CI)
0.617 (0.519-0.733)
0.701 (0.575-0.854)
rs3130932 with ventilation situation
TT
No
14 (1.3)
7 (0.6)
1.000
1.000
TT
Yes
439 (42.0)
446 (41.2)
0.492 (0.197-1.231)
0.516 (0.190-1.402)
GT+GG
No
24 (2.3)
8 (0.7)
1.500 (0.447-5.029)
1.086 (0.292-4.045)
GT+GG
Yes
568 (54.4)
621 (57.4)
0.457 (0.183-1.141)
0.473 (0.174-1.282)
rs3130932 × ventilation situation
ORmultiply (95% CI)
0.884 (0.745-1.049)
1.638 (1.149-2.334)
rs3130932 with kitchen ventilator
TT
No
204 (19.5)
147 (13.6)
1.000
1.000
TT
Yes
249 (23.8)
306 (28.3)
0.586 (0.448-0.768)
1.036 (0.752-1.427)
GT+GG
No
246 (23.5)
179 (16.5)
0.990 (0.744-1.319)
1.025 (0.744-1.411)
GT+GG
Yes
346 (33.1)
450 (41.6)
0.554 (0.430-0.714)
0.894 (0.662-1.207)
rs3130932 × kitchen ventilator
ORmultiply (95% CI)
0.695 (0.583-0.830)
0.872 (0.711-1.070)
rs3130932 with COF
TT
No
85 (8.1)
150 (13.9)
1.000
1.000
TT
Yes
368 (35.2)
303 (28.0)
2.143 (1.578-2.912)
1.744 (1.238-2.458)
GT+GG
No
96 (9.2)
191 (17.7)
0.887 (0.618-1.274)
0.849 (0.568-1.268)
GT+GG
Yes
496 (47.5)
438 (40.5)
1.998 (1.487-2.685)
1.643 (1.180-2.287)
rs3130932 × COF
ORmultiply (95% CI)
1.328 (1.119-1.577)
0.951 (0.895-1.011)
rs3130932 with smoking
TT
No
170 (16.3)
268 (24.8)
1.000
1.000
TT
Yes
283 (27.1)
185 (17.1)
2.412 (1.847-3.149)
2.016 (1.477-2.752)
GT+GG
No
223 (21.3)
370 (34.2)
0.950 (0.737-1.225)
0.929 (0.702-1.229)
GT+GG
Yes
369 (35.3)
259 (23.9)
2.246 (1.750-2.882)
1.835 (1.372-2.455)
rs3130932 × smoking
ORmultiply (95% CI)
1.735 (1.436-2.095)
1.421 (1.145-1.764)
rs3130932 with passive smoking
TT
No
133 (12.7)
260 (24.0)
1.000
1.000
TT
Yes
320 (30.6)
193 (17.8)
3.241 (2.467-4.267)
2.598 (1.921-3.513)
GT+GG
No
178 (17.0)
340 (31.4)
1.023 (0.776-1.350)
1.006 (0.744-1.361)
GT+GG
Yes
414 (39.6)
289 (26.7)
2.800 (2.165-3.622)
2.237 (1.685-2.970)
rs3130932 × passive smoking
ORmultiply (95% CI)
1.800 (1.499-2.162)
1.548 (1.263-1.897)
rs3130932 with drink alcohol
TT
No
296 (28.3)
325 (30.0)
1.000
1.000
TT
Yes
157 (15.0)
128 (11.8)
1.347 (1.016-1.785)
0.861 (0.621-1.194)
GT+GG
No
385 (36.8)
449 (41.5)
0.941 (0.765-1.159)
0.910 (0.719-1.152)
GT+GG
Yes
207 (19.8)
180 (16.6)
1.263 (0.979-1.628)
0.808 (0.598-1.091)
rs3130932 × drink alcohol
ORmultiply (95% CI)
1.238 (0.993-1.544)
0.872 (0.674-1.129)
rs3130932 with history of lung disease
TT
No
398 (38.1)
417 (38.5)
1.000
1.000
TT
Yes
55 (5.3)
36 (3.3)
1.601 (1.029-2.491)
1.495 (0.909-2.460)
GT+GG
No
524 (50.1)
575 (53.1)
0.955 (0.796-1.145)
0.934 (0.761-1.145)
GT+GG
Yes
68 (6.5)
54 (5.0)
1.319 (0.900-1.935)
1.185 (0.762-1.841)
rs3130932 × history of lung disease
ORmultiply (95% CI)
1.412 (1.065-1.871)
1.205 (0.789-1.843)
rs3130932 with family history of cancer
TT
No
369 (35.3)
387 (35.8)
1.000
1.000
TT
Yes
84 (8.0)
66 (6.1)
1.335 (0.938-1.899)
1.267 (0.855-1.878)
GT+GG
No
467 (44.7)
534 (49.4)
0.917 (0.759-1.108)
0.877 (0.708-1.085)
GT+GG
Yes
125 (12.0)
95 (8.8)
1.380 (1.020-1.867)
1.462 (1.037-2.061)
rs3130932 × family history of cancer
ORmultiply (95% CI)
1.412 (1.065-1.871)
1.537 (1.117-2.116)
#By the degree of education, marital status, BMI, pollution near the place of residence, house type, ventilation situation, COF, kitchen ventilator, smoking, passive smoking, drink alcohol, history of lung disease, and family history of cancer adjusted. OR and its interval shown in italic font to represent the P<0.05.Table 6
Joint and multiplication interaction between gene recessive model and environmental factors.
Genotype
Environment
Case (%)
Control (%)
OR (95% CI)
aOR (95% CI)#
rs13409
N=1022
N=1053
rs13409 with pollution near the place of residence
CT+CC
No
736 (72.0)
866 (82.2)
1.000
1.000
CT+CC
Yes
165 (16.1)
78 (7.4)
2.489 (1.869-3.315)
2.224 (1.624-3.046)
TT
No
88 (8.6)
103 (9.8)
1.005 (0.744-1.358)
0.909 (0.649-1.272)
TT
Yes
33 (3.2)
6 (0.6)
6.471 (2.697-15.530)
6.308 (2.516-15.815)
rs13409 × pollution near the place of residence
ORmultiply (95% CI)
5.823 (2.429-13.956)
5.766 (2.302-14.444)
rs13409 with house type
CT+CC
No
303 (29.6)
156 (14.8)
1.000
1.000
CT+CC
Yes
598 (58.5)
788 (74.8)
0.402 (0.302-0.535)
0.448 (0.328-0.613)
TT
No
45 (4.4)
17 (1.6)
2.600 (1.046-6.463)
2.935 (1.131-7.617)
TT
Yes
76 (7.4)
92 (8.7)
0.404 (0.273-0.598)
0.401 (0.261-0.617)
rs13409 × house type
ORmultiply (95% CI)
1.009 (0.866-1.175)
0.846 (0.595-1.203)
rs13409 with ventilation situation
CT+CC
No
31 (3.0)
13 (1.2)
1.000
1.000
CT+CC
Yes
870 (85.1)
931 (88.4)
0.392 (0.204-0.754)
0.509 (0.248-1.045)
TT
No
5 (0.5)
2 (0.2)
1.048 (0.180-6.112)
1.311 (0.194-8.848)
TT
Yes
116 (11.4)
107 (10.2)
0.455 (0.226-0.914)
0.544 (0.252-1.175)
rs13409 × ventilation situation
ORmultiply (95% CI)
1.132 (0.857-1.495)
2.274 (1.095-4.724)
rs13409 with kitchen ventilator
CT+CC
No
381 (37.3)
275 (26.1)
1.000
1.000
CT+CC
Yes
520 (50.9)
669 (63.5)
0.561 (0.463-0.680)
0.913 (0.718-1.160)
TT
No
58 (5.7)
40 (3.8)
1.047 (0.680-1.612)
0.934 (0.577-1.512)
TT
Yes
63 (6.2)
69 (6.6)
0.659 (0.453-0.959)
1.046 (0.680-1.608)
rs13409 × kitchen ventilator
ORmultiply (95% CI)
0.937 (0.658-1.333)
1.117 (0.752-1.658)
rs13409 with COF
CT+CC
No
149 (14.6)
311 (29.5)
1.000
1.000
CT+CC
Yes
752 (73.6)
633 (60.1)
2.480 (1.986-3.096)
2.177 (1.696-2.794)
TT
No
23 (2.3)
24 (2.3)
2.000 (1.093-3.661)
2.403 (1.236-4.673)
TT
Yes
98 (9.6)
85 (8.1)
2.406 (1.696-3.415)
1.864 (1.260-2.759)
rs13409 × COF
ORmultiply (95% CI)
1.208 (0.891-1.637)
1.015 (0.916-1.124)
rs13409 with smoking
CT+CC
No
351 (34.3)
561 (53.3)
1.000
1.000
CT+CC
Yes
550 (53.8)
383 (36.4)
2.295 (1.905-2.766)
1.954 (1.559-2.450)
TT
No
40 (3.9)
64 (6.1)
0.999 (0.658-1.516)
0.935 (0.592-1.477)
TT
Yes
81 (7.9)
45 (4.3)
2.877 (1.952-4.241)
2.287 (1.468-3.563)
rs13409 × smoking
ORmultiply (95% CI)
1.928 (1.325-2.086)
1.515 (0.995-2.307)
rs13409 with passive smoking
CT+CC
No
271 (26.5)
528 (50.1)
1.000
1.000
CT+CC
Yes
630 (61.6)
416 (39.5)
2.951 (2.436-3.574)
2.403 (1.945-2.969)
TT
No
36 (3.5)
56 (5.3)
1.253 (0.804-1.925)
1.111 (0.683-1.807)
TT
Yes
85 (8.3)
53 (5.0)
3.125 (2.152-4.537)
2.445 (1.622-3.684)
rs13409 × passive smoking
ORmultiply (95% CI)
1.712 (1.201-2.440)
1.475 (0.997-2.181)
rs13409 with drink alcohol
CT+CC
No
598 (58.5)
675 (64.1)
1.000
1.000
CT+CC
Yes
303 (29.6)
269 (25.5)
1.271 (1.043-1.549)
0.829 (0.652-1.052)
TT
No
73 (7.1)
75 (7.1)
1.099 (0.782-1.544)
0.983 (0.669-1.444)
TT
Yes
48 (4.7)
34 (3.2)
1.594 (1.013-2.506)
0.992 (0.594-1.659)
rs13409 × drink alcohol
ORmultiply (95% CI)
1.477 (0.944-2.312)
1.070 (0.647-1.768)
rs13409 with history of lung disease
CT+CC
No
793 (77.6)
859 (81.6)
1.000
1.000
CT+CC
Yes
108 (10.6)
85 (8.1)
1.376 (1.019-1.858)
1.289 (0.915-1.816)
TT
No
101 (9.9)
105 (10.0)
1.042 (0.780-1.392)
0.944 (0.682-1.308)
TT
Yes
20 (2.0)
4 (0.4)
5.416 (1.843-15.914)
4.406 (1.394-13.930)
rs13409 × history of lung disease
ORmultiply (95% CI)
5.235 (1.783-15.368)
4.313 (1.366-13.620)
rs13409 with family history of cancer
CT+CC
No
714 (69.9)
805 (76.4)
1.000
1.000
CT+CC
Yes
187 (18.3)
139 (13.2)
1.517 (1.191-1.931)
1.522 (1.160-1.998)
TT
No
101 (9.9)
91 (8.6)
1.251 (0.926-1.690)
1.101 (0.784-1.546)
TT
Yes
20 (2.0)
18 (1.7)
1.253 (0.657-2.387)
1.296 (0.632-2.661)
rs13409 × family history of cancer
ORmultiply (95% CI)
1.148 (0.604-2.182)
1.197 (0.584-2.453)
rs6815391
N=1020
N=1033
rs6815391 with pollution near the place of residence
TT+CT
No
733 (71.9)
832 (80.5)
1.000
1.000
TT+CT
Yes
182 (17.8)
75 (7.3)
2.754 (2.068-3.669)
2.474 (1.812-3.377)
CC
No
88 (8.6)
115 (11.1)
0.869 (0.647-1.166)
1.001 (0.721-1.389)
CC
Yes
17 (1.7)
11 (1.1)
1.754 (0.816-3.769)
1.963 (0.855-4.505)
rs6815391 × pollution near the place of residence
ORmultiply (95% CI)
1.575 (0.734-3.379)
1.754 (0.764-4.026)
rs6815391 with house type
TT+CT
No
302 (29.6)
144 (13.9)
1.000
1.000
TT+CT
Yes
613 (60.1)
763 (73.9)
0.383 (0.306-0.480)
0.508 (0.391-0.661)
CC
No
32 (3.1)
21 (2.0)
0.727 (0.405-1.304)
0.844 (0.445-1.602)
CC
Yes
73 (7.2)
105 (10.2)
0.332 (0.232-0.474)
0.517 (0.344-0.777)
rs6815391 × house type
ORmultiply (95% CI)
0.681 (0.499-0.931)
0.875 (0.616-1.243)
rs6815391 with ventilation situation
TT+CT
No
36 (3.5)
13 (1.3)
1.000
1.000
TT+CT
Yes
879 (86.2)
894 (86.5)
0.355 (0.187-0.674)
0.412 (0.204-0.831)
CC
No
2 (0.2)
2 (0.2)
0.361 (0.046-2.838)
0.193 (0.021-1.757)
CC
Yes
103 (10.1)
124 (12.0)
0.300 (0.151-0.596)
0.410 (0.193-0.869)
rs6815391 × ventilation situation
ORmultiply (95% CI)
0.823 (0.624-1.086)
1.031 (0.466-2.281)
rs6815391 with kitchen ventilator
TT+CT
No
402 (39.4)
279 (27.0)
1.000
1.000
TT+CT
Yes
513 (50.3)
628 (60.8)
0.567 (0.468-0.687)
0.910 (0.717-1.155)
CC
No
33 (3.2)
28 (2.7)
0.818 (0.483-1.384)
0.860 (0.478-1.547)
CC
Yes
72 (7.1)
98 (9.5)
0.510 (0.363-0.717)
0.927 (0.627-1.372)
rs6815391 × kitchen ventilator
ORmultiply (95% CI)
0.725 (0.528-0.995)
0.994 (0.698-1.415)
rs6815391 with COF
TT+CT
No
150 (14.7)
290 (28.1)
1.000
1.000
TT+CT
Yes
765 (75.0)
617 (59.7)
2.397 (1.916-2.998)
1.999 (1.554-2.571)
CC
No
25 (2.5)
47 (4.5)
1.028 (0.609-1.736)
1.080 (0.614-1.900)
CC
Yes
80 (7.8)
79 (7.6)
1.958 (1.355-2.829)
1.855 (1.232-2.791)
rs6815391 × COF
ORmultiply (95% CI)
1.028 (0.744-1.421)
0.960 (0.872-1.057)
rs6815391 with smoking
TT+CT
No
349 (34.2)
536 (51.9)
1.000
1.000
TT+CT
Yes
566 (55.5)
371 (35.9)
2.343 (1.942-2.827)
2.008 (1.596-2.525)
CC
No
39 (3.8)
82 (7.9)
0.730 (0.487-1.094)
0.858 (0.555-1.328)
CC
Yes
66 (6.5)
44 (4.3)
2.304 (1.537-3.453)
2.221 (1.417-3.482)
rs6815391 × smoking
ORmultiply (95% CI)
1.555 (1.051-2.301)
1.531 (0.994-2.359)
rs6815391 with passive smoking
TT+CT
No
273 (26.8)
499 (48.3)
1.000
1.000
TT+CT
Yes
642 (62.9)
408 (39.5)
2.876 (2.372-3.488)
2.253 (1.822-2.786)
CC
No
38 (3.7)
75 (7.3)
0.926 (0.610-1.406)
0.895 (0.569-1.409)
CC
Yes
67 (6.6)
51 (4.9)
2.401 (1.621-3.557)
2.356 (1.530-3.629)
rs6815391 × passive smoking
ORmultiply (95% CI)
1.354 (0.930-1.970)
1.516 (1.000-2.300)
rs6815391 with drink alcohol
TT+CT
No
603 (59.1)
658 (63.7)
1.000
1.000
TT+CT
Yes
312 (30.6)
249 (24.1)
1.367 (1.120-1.670)
0.874 (0.686-1.112)
CC
No
71 (7.0)
91 (8.8)
0.851 (0.612-1.184)
0.981 (0.678-1.420)
CC
Yes
34 (3.3)
35 (3.4)
1.060 (0.653-1.721)
0.833 (0.484-1.435)
rs6815391 × drink alcohol
ORmultiply (95% CI)
0.983 (0.608-1.589)
0.877 (0.515-1.496)
rs6815391 with history of lung disease
TT+CT
No
800 (78.4)
841 (81.4)
1.000
1.000
TT+CT
Yes
115 (11.3)
66 (6.4)
1.832 (1.333-2.517)
1.702 (1.186-2.445)
CC
No
96 (9.4)
115 (11.1)
0.878 (0.658-1.170)
1.032 (0.748-1.424)
CC
Yes
9 (0.9)
11 (1.1)
0.860 (0.355-2.087)
0.906 (0.340-2.416)
rs6815391 × history of lung disease
ORmultiply (95% CI)
0.827 (0.341-2.004)
0.853 (0.320-2.277)
rs6815391 with family history of cancer
TT+CT
No
736 (72.2)
768 (74.3)
1.000
1.000
TT+CT
Yes
179 (17.5)
139 (13.5)
1.344 (1.053-1.714)
1.409 (1.072-1.852)
CC
No
82 (8.0)
108 (10.5)
0.792 (0.584-1.074)
0.940 (0.670-1.319)
CC
Yes
23 (2.3)
18 (1.7)
1.333 (0.714-2.491)
1.614 (0.795-3.274)
rs6815391 × family history of cancer
ORmultiply (95% CI)
1.301 (0.698-2.425)
1.535 (0.758-3.106)
rs3740535
N=1048
N=1079
rs3740535 with pollution near the place of residence
GA+GG
No
779 (74.3)
934 (86.6)
1.000
1.000
GA+GG
Yes
196 (18.7)
81 (7.5)
2.901 (2.202-3.823)
2.669 (1.976-3.605)
AA
No
61 (5.8)
58 (5.4)
1.261 (0.869-1.829)
1.188 (0.784-1.800)
AA
Yes
12 (1.1)
6 (0.6)
2.398 (0.896-6.419)
1.624 (0.537-4.911)
rs3740535 × pollution near the place of residence
ORmultiply (95% CI)
2.071 (0.775-5.540)
1.419 (0.470-4.289)
rs3740535 with house type
GA+GG
No
322 (30.7)
166 (15.4)
1.000
1.000
GA+GG
Yes
653 (62.3)
849 (78.7)
0.397 (0.320-0.491)
0.516 (0.403-0.661)
AA
No
33 (3.1)
12 (1.1)
1.418 (0.713-2.817)
1.232 (0.578-2.624)
AA
Yes
40 (3.8)
52 (4.8)
0.397 (0.252-0.624)
0.546 (0.331-0.898)
rs3740535 × house type
ORmultiply (95% CI)
0.784 (0.514-1.194)
0.875 (0.548-1.395)
rs3740535 with ventilation situation
GA+GG
No
37 (3.5)
13 (1.2)
1.000
1.000
GA+GG
Yes
938 (89.5)
1002 (92.9)
0.329 (0.174-0.623)
0.384 (0.191-0.773)
AA
No
2 (0.2)
3 (0.3)
0.234 (0.035-1.562)
0.109 (0.013-0.925)
AA
Yes
71 (6.8)
61 (5.7)
0.409 (0.199-0.839)
0.450 (0.204-0.992)
rs3740535 × ventilation situation
ORmultiply (95% CI)
1.213 (0.852-1.727)
1.476 (0.475-4.529)
rs3740535 with kitchen ventilator
GA+GG
No
400 (38.2)
305 (28.3)
1.000
1.000
GA+GG
Yes
575 (54.9)
710 (65.8)
0.618 (0.513-0.743)
1.013 (0.804-1.275)
AA
No
50 (4.8)
19 (1.8)
2.007 (1.159-3.474)
2.027 (1.170-3.730)
AA
Yes
23 (2.2)
45 (4.2)
0.390 (0.231-0.658)
0.656 (0.366-1.178)
rs3740535 × kitchen ventilator
ORmultiply (95% CI)
0.516 (0.310-0.858)
0.641 (0.365-1.123)
rs3740535 with COF
GA+GG
No
170 (16.2)
321 (29.7)
1.000
1.000
GA+GG
Yes
805 (76.8)
694 (64.3)
2.190 (1.772-2.707)
1.851 (1.458-2.349)
AA
No
10 (1.0)
21 (1.9)
0.899 (0.414-1.953)
0.887 (0.386-2.039)
AA
Yes
63 (6.0)
43 (4.0)
2.766 (1.800-4.253)
2.163 (1.329-3.521)
rs3740535 × COF
ORmultiply (95% CI)
1.541 (1.036-2.293)
1.017 (0.895-1.155)
rs3740535 with smoking
GA+GG
No
376 (35.9)
595 (55.1)
1.000
1.000
GA+GG
Yes
599 (57.2)
420 (38.9)
2.257 (1.886-2.701)
1.900 (1.525-2.367)
AA
No
24 (2.3)
40 (3.7)
0.949 (0.563-1.601)
0.903 (0.510-1.598)
AA
Yes
49 (4.7)
24 (2.2)
3.231 (1.950-5.354)
2.539 (1.442-4.471)
rs3740535 × smoking
ORmultiply (95% CI)
2.156 (1.313-3.540)
1.781 (1.024-3.100)
rs3740535 with passive smoking
GA+GG
No
283 (27.0)
557 (51.6)
1.000
1.000
GA+GG
Yes
692 (66.0)
458 (42.4)
2.974 (2.470-3.580)
2.406 (1.961-2.952)
AA
No
27 (2.6)
38 (3.5)
1.398 (0.837-2.337)
1.133 (0.641-2.005)
AA
Yes
46 (4.4)
26 (2.4)
3.48 2 (2.108-5.751)
2.591 (1.495-4.489)
rs3740535 × passive smoking
ORmultiply (95% CI)
1.859 (1.141-3.031)
1.560 (0.909-2.679)
rs3740535 with drink alcohol
GA+GG
No
636 (60.7)
719 (66.6)
1.000
1.000
GA+GG
Yes
339 (32.3)
296 (27.4)
1.295 (1.072-1.564)
0.847 (0.673-1.064)
AA
No
48 (4.6)
51 (4.7)
1.064 (0.707-1.601)
0.906 (0.569-1.443)
AA
Yes
25 (2.4)
13 (1.2)
2.174 (1.103-4.285)
1.566 (0.731-3.355)
rs3740535 × drink alcohol
ORmultiply (95% CI)
2.004 (1.020-3.938)
1.683 (0.791-3.577)
rs3740535 with history of lung disease
GA+GG
No
859 (82.0)
935 (86.7)
1.000
1.000
GA+GG
Yes
116 (11.1)
80 (7.4)
1.578 (1.170-2.129)
1.467 (1.043-2.064)
AA
No
64 (6.1)
55 (5.1)
1.267 (0.873-1.838)
1.199 (0.786-1.829)
AA
Yes
9 (0.9)
9 (0.8)
1.088 (0.430-2.755)
0.920 (0.320-2.644)
rs3740535 × history of lung disease
ORmultiply (95% CI)
1.030 (0.407-2.605)
0.880 (0.306-2.529)
rs3740535 with family history of cancer
GA+GG
No
783 (74.7)
866 (80.3)
1.000
1.000
GA+GG
Yes
192 (18.3)
149 (13.8)
1.425 (1.127-1.802)
1.551 (1.191-2.019)
AA
No
54 (5.2)
53 (4.9)
1.127 (0.762-1.666)
1.209 (0.779-1.874)
AA
Yes
19 (1.8)
11 (1.0)
1.910 (0.903-4.040)
1.189 (0.517-2.738)
rs3740535 × family history of cancer
ORmultiply (95% CI)
1.793 (0.849-3.786)
1.094 (0.476-2.510)
rs3130932
N=1045
N=1082
rs3130932 with pollution near the place of residence
GT+TT
No
728 (69.7)
867 (80.1)
1.000
1.000
GT+TT
Yes
185 (17.7)
80 (7.4)
2.754 (2.081-3.645)
2.418 (1.780-3.284)
GG
No
110 (10.5)
129 (11.9)
1.016 (0.773-1.334)
1.028 (0.757-1.396)
GG
Yes
22 (2.1)
6 (0.6)
4.367 (1.761-10.827)
4.881 (1.849-12.885)
rs3130932 × pollution near the place of residence
ORmultiply (95% CI)
3.857 (1.557-9.550)
4.354 (1.649-11.495)
rs3130932 with house type
GT+TT
No
302 (28.9)
153 (14.1)
1.000
1.000
GT+TT
Yes
611 (58.5)
794 (73.4)
0.390 (0.312-0.486)
0.542 (0.419-0.701)
GG
No
54 (5.2)
25 (2.3)
1.094 (0.656-1.827)
1.433 (0.817-2.513)
GG
Yes
78 (7.5)
110 (10.2)
0.359 (0.253-0.509)
0.535 (0.360-0.795)
rs3130932 × house type
ORmultiply (95% CI)
0.713 (0.526-0.965)
0.832 (0.591-1.171)
rs3130932 with ventilation situation
GT+TT
No
34 (3.3)
14 (1.3)
1.000
1.000
GT+TT
Yes
879 (84.1)
933 (86.2)
0.388 (0.207-0.728)
0.503 (0.253-0.998)
GG
No
4 (0.4)
1 (0.1)
1.647 (0.169-16.070)
2.456 (0.214-28.192)
GG
Yes
128 (12.2)
134 (12.4)
0.393 (0.202-0.767)
0.534 (0.257-1.110)
rs3130932 × ventilation situation
ORmultiply (95% CI)
0.988 (0.762-1.279)
1.063 (0.500-2.262)
rs3130932 with kitchen ventilator
GT+TT
No
396 (37.9)
286 (26.4)
1.000
1.000
GT+TT
Yes
517 (49.5)
661 (61.1)
0.565 (0.467-0.684)
0.926 (0.730-1.173)
GG
No
54 (5.2)
40 (3.7)
0.975 (0.630-1.508)
1.045 (0.646-1.689)
GG
Yes
78 (7.5)
95 (8.8)
0.593 (0.424-0.830)
1.040 (0.704-1.537)
rs3130932 × kitchen ventilator
ORmultiply (95% CI)
0.838 (0.613-1.145)
1.093 (0.767-1.559)
rs3130932 with COF
GT+TT
No
162 (15.5)
297 (27.4)
1.000
1.000
GT+TT
Yes
751 (71.9)
650 (60.1)
2.118 (1.703-2.635)
1.823 (1.426-2.332)
GG
No
19 (1.8)
44 (4.1)
0.792 (0.447-1.401)
1.017 (0.547-1.892)
GG
Yes
113 (10.8)
91 (8.4)
2.277 (1.627-3.185)
2.007 (1.378-2.923)
rs3130932 × COF
ORmultiply (95% CI)
1.320 (0.988-1.765)
1.013 (0.922-1.112)
rs3130932 with smoking
GT+TT
No
341 (32.6)
557 (51.5)
1.000
1.000
GT+TT
Yes
572 (54.7)
390 (36.0)
2.396 (1.988-2.886)
2.016 (1.607-2.529)
GG
No
52 (5.0)
81 (7.5)
1.049 (0.722-1.523)
1.144 (0.759-1.724)
GG
Yes
80 (7.7)
54 (5.0)
2.420 (1.671-3.505)
2.113 (1.389-3.212)
rs3130932 × smoking
ORmultiply (95% CI)
1.578 (1.105-2.253)
1.414 (0.950-2.106)
rs3130932 with passive smoking
GT+TT
No
273 (26.1)
519 (48.0)
1.000
1.000
GT+TT
Yes
640 (61.2)
428 (39.6)
2.843 (2.349-3.441)
2.296 (1.859-2.834)
GG
No
38 (3.6)
81 (7.5)
0.892 (0.591-1.347)
0.934 (0.597-1.460)
GG
Yes
94 (9.0)
54 (5.0)
3.309 (2.297-4.769)
2.835 (1.899-4.233)
rs3130932 × passive smoking
ORmultiply (95% CI)
1.882 (1.331-2.660)
1.778 (1.214-2.604)
rs3130932 with drink alcohol
GT+TT
No
592 (56.7)
678 (62.7)
1.000
1.000
GT+TT
Yes
321 (30.7)
269 (24.9)
1.367 (1.123-1.663)
0.882 (0.696-1.119)
GG
No
89 (8.5)
96 (8.9)
1.062 (0.780-1.446)
1.111 (0.785-1.573)
GG
Yes
43 (4.1)
39 (3.6)
1.263 (0.807-1.975)
0.934 (0.560-1.557)
rs3130932 × drink alcohol
ORmultiply (95% CI)
1.148 (0.738-1.786)
0.968 (0.586-1.598)
rs3130932 with history of lung disease
GT+TT
No
805 (77.0)
872 (80.6)
1.000
1.000
GT+TT
Yes
108 (10.3)
75 (6.9)
1.560 (1.144-2.126)
1.478 (1.037-2.105)
GG
No
117 (11.2)
120 (11.1)
1.056 (0.805-1.386)
1.165 (0.857-1.583)
GG
Yes
15 (1.4)
15 (1.4)
1.083 (0.526-2.230)
0.962 (0.421-2.196)
rs3130932 × history of lung disease
ORmultiply (95% CI)
1.036 (0.504-2.130)
0.914 (0.401-2.085)
rs3130932 with family history of cancer
GT+TT
No
731 (70.0)
809 (74.8)
1.000
1.000
GT+TT
Yes
182 (17.4)
138 (12.8)
1.460 (1.145-1.861)
1.484 (1.129-1.950)
GG
No
105 (10.0)
112 (10.3)
1.038 (0.781-1.379)
1.093 (0.793-1.507)
GG
Yes
27 (2.6)
23 (2.1)
1.299 (0.738-2.286)
1.632 (0.862-3.092)
rs3130932 × family history of cancer
ORmultiply (95% CI)
1.221 (0.696-2.144)
1.520 (0.805-2.873)
#By the degree of education, marital status, BMI, pollution near the place of residence, house type, ventilation situation, COF, kitchen ventilator, smoking, passive smoking, drink alcohol, history of lung disease, and family history of cancer adjusted. OR and its interval shown in italic font to represent the P<0.05.The interaction analysis for both the dominant or recessive models showed that there was no additive interaction between theREX1 rs6815391, OCT4 rs13409 or rs3130932, or CTBP2 rs3740535 polymorphisms with smoking (Table 7).Table 7
Smoking interaction with four gene loci.
RERI
AP
S
rs13409 dominant genetic model
Smoking
0.047
0.010
1.013
(-1.232-1.325)
(-0.264-0.284)
(0.712-1.441)
rs13409 recessive genetic model
Smoking
-0.638
-0.160
0.824
(-2.689-1.412)
(-0.658-0.338)
(0.478-1.422)
rs3130932 dominant genetic model
Smoking
0.303
0.074
1.108
(-0.805-1.411)
(-0.186-0.333)
(0.761-1.611)
rs3130932 recessive genetic model
Smoking
-0.107
-0.031
0.958
(-1.673-1.459)
(-0.488-0.425)
(0.516-1.776)
rs3740535 dominant genetic model
Smoking
-0.460
-0.116
0.866
(--1.662-0.742)
(-0.428-0.195)
(0.601-1.247)
rs3740535 recessive genetic model
Smoking
-1.240
-0.306
0.711
(-4.376-1.896)
(-1.036-0.423)
(0.359-1.409)
rs6815391 dominant genetic model
Smoking
-1.007
-0.247
0.754
(-2.298-0.284)
(-0.584-0.090)
(0.532-1.067)
rs6815391 recessive genetic model
Smoking
-0.657
-0.154
0.833
(-2.855-1.541)
(-656-0.349)
(0.483-1.437)


## 3.5. Multivariate Analysis

As can be observed in Tables2 and 3, REX1 rs6815391 CT+CC, OCT4 rs13409 CT+TT, and rs3130932 GT+TT were three protective genotypes, and the combination could be divided into three classes. In a collinear diagnosis, the results of multivariate analysis, marital status, BMI, COF, smoking, passive smoking, family history of cancer, history of lung disease, and lung cancer susceptibility were all independent risk factors. College or above, well ventilation, one or two protective genotypes, and no pollution near the place of residence reduced the occurrence of lung cancer (Table 8).Table 8
Multivariate analysis.
Variable
B
P
OR (OR 95% CI)
Junior and senior high school
0.125
0.442
1.133 (0.824-1.556)
College degree or above
-0.329
0.036
0.719 (0.529-0.978)
Others (marital status)
1.889
0.006
6.615 (1.704-25.678)
Single (marital status)
1.813
0.012
6.126 (1.495-25.101)
18.5<BMI<23.9
1.300
<0.001
3.674 (2.487-5.419)
BMI≥24
0.512
<0.001
1.669 (1.365-2.041)
Building (with cottage ratio)
0.409
0.436
1.505 (0.538-4.209)
Ventilation general
-0.805
0.014
0.447 (0.235-0.851)
Ventilation worse
-0.103
0.767
0.902 (0.455-1.787)
Not pollution near the place of residence
-0.843
<0.001
0.430 (0.325-0.569)
Kitchen ventilator
-0.051
0.648
0.950 (0.764-1.182)
Much fumes
1.115
<0.001
3.049 (1.674-5.556)
Some fumes
0.535
<0.001
1.708 (1.278-2.282)
Little fumes
0.630
<0.001
1.877 (1.485-2.373)
Smoking
0.653
<0.001
1.921 (1.564-2.360)
Passive smoking
0.865
<0.001
2.374 (1.959-2.878)
History of lung disease
0.333
0.037
1.394 (1.020-1.907)
Family history of cancer
0.348
0.006
1.417 (1.106-1.814)
Drink alcohol
-0.104
0.349
0.901 (0.725-1.120)
1 protected genotypes
-0.486
0.006
0.615 (0.436-0.868)
2 protected genotypes
-0.291
0.030
0.747 (0.575-0.972)
3 protected genotypes
-0.154
0.199
0.857 (0.677-1.085)
#OR and its interval shown in italic font to represent the P<0.05.


## 4. Discussion

In our current study, the relationship between each of the four SNPs and the risk of lung cancer among 1121 patients and 1121 controls were estimated. The unconditional logistic regression analysis results showed no association betweenREX1 rs6815391, OCT4 rs3130932, or CTBP2 rs3740535 with lung cancer susceptibility, whereas OCT4 rs13409 was associated with lung cancer susceptibility. In the co-dominant model, the lung cancer risk of the OCT4 rs13409 CT genotype carriers was 0.731-fold that of the CC genotype carriers (95% CI: 0.595-0.899); in the dominant model, the risk of lung cancer in the CT+TT genotype carriers was 0.765-fold that of the CC carriers (95% CI: 0.629-0.930).REX1, also known as Zfp42, belongs to the zinc finger protein C2H2 family and is one of the subgroup members of the transcription factor YY1 (Yin Yang 1) [27]. The expression of the REX1 molecule occurs mainly in the early stages of embryonic development, and its deletion may not directly affect the differentiation direction of ES cells but may play a role in the late developmental stage [28].The expression ofREX1 was detected in different cells, such as bone marrow, heart, human epidermal keratinocytes, prostate, and lung-derived epithelial cells but disappeared with the increase in cell passage times, suggesting that REX1 expression is closely related to cell self-renewal [15]. The REX1 promoter contains binding sites for multiple core transcription factors and has a two-way regulatory effect with the OCT4 gene, which plays a role in the pluripotency of stem cells. Some scholars [29] have found a novel mechanism between OCT4 and REX1 in which Drp1 fission activity partially contributes to the pluripotency in hESCs (human embryonic stem cells). REX1 achieves mitochondrial fission by reducing the reprogramming barrier (growth stagnation and apoptosis), as well as the process of converting from oxidative phosphorylation to glycolytic metabolism, which depends on the cyclin B1/B2-DRP1 pathway, altering cell cycle progression and the metabolism state to allow stem cells to enter and exit pluripotency [30].Studies on the association between theREX1 gene and tumors are rare. The current study found no association between REX1 rs6815391 polymorphism and lung cancer susceptibility. The stratified analysis of different pathological types of adenocarcinoma also showed no significant difference. However, our results suggested that the TT genotype may be associated with other risks of lung cancer, such as pollution near the place of residence, house type, ventilation situation, COF, smoking, passive smoking, lung disease history, and family history of cancer.OCT4 is encoded by Pou5f1 and belongs to the POU (Pit-Oct-Unc) transcription factor family and participates in the regulation of downstream genes by binding an octa-base conserved sequence containing ATGCAAAT [31]. The OCT4 gene is the “core” of stem cells. Some studies [32] have found that the differentiation and maturation of tumor cells are related to the downregulation of OCT4 expression. Stem cells can also secrete OCT4 and VEGF to promote the origin of tumor epithelial cells into vascular epithelial cells and form small blood vessels for maintaining the survival of dry cells under hypoxia to induce tumor blood transfer for the foundation of resistance to chemotherapy [33]. Our study found that in adenocarcinoma, OCT4 rs13409 in a co-dominant model CT genotype showed 0.689-fold the risk of lung cancer in CC carriers (95% CI: 0.536-0.885); in dominant models, the risk of lung cancer in CT+TT carriers was 0.745-fold higher than that of CC carriers (95% CI: 0.589-0.941). In all subtypes of lung cancers, the risk of OCT4 rs13409 CT genotype carriers in the co-dominant genetic model was 0.734-fold that of the CC carriers (95% CI: 0.610-0.884), and the risk of CT+TT carriers in the recessive model was 0.781-fold that of the CC carriers (95% CI: 0.656-0.930). In squamous carcinoma, the risk of lung cancer in the OCT4 rs3130932 GG carriers in the recessive model was 1.569-fold as high as that of the GT+TT carriers (95% CI: 1.016-2.425).After analyzing the interaction between the two genotypes ofOCT4 and environmental factors (pollution near the place of residence, house type, COF, ventilation situation, kitchen ventilator, smoking, passive smoking, alcohol drinking, history of lung disease, and family history of cancer), our results showed that the OCT4 rs13409 dominant model had a combined effect with these environmental factors, while two genotypes of OCT4 in the recessive model had an interaction with the environmental factors except for alcohol drinking and kitchen ventilator. The OCT4 rs3130932 dominant model interacted with these environmental factors with the exception of alcohol drinking, kitchen ventilator, and history of lung disease. The OCT4 rs13409CC and OCT4 rs3130932GG genotypes were also found to be risk factors for lung cancer. OCT4 rs13409 showed [34] a significant association with multiple myeloma risk in 1,832 controls and 2,894 MM from seven European countries and Israel. In northern Iran [35], the OCT4 rs3130932G allele was associated with the incidence of gastric cancer; genotypes AC [P=0.031, OR=0.63 (0.44-0.91)] and AC+CC [P=0.031, OR=0.68 (0.48-0.95)] had protective effects on patients in north India [36]. In Greece [37], however, there was no significant association between the genotype tested and the risk of breast, ovarian, or lung cancer.Vertebrates contain two differentCTBP2 genes, which are located on human chromosomes 4p16 and l0q26.13, encoding CTBP1 and CTBP2 proteins, and both are structurally highly homologous [38]. A variety of transcription factors interact directly or indirectly with CTBP, and some of these are related to stem cell maintenance or development [39]. CTBP2 is a transcriptional corepressor and a regulator during exit from pluripotency [40]. CTBP2 binds transcription factors through a Pro-X-Asp-Leu-Ser motif and recruits epigenetic remodelers to form the complex [41]. The overexpression of the CtBP2 protein in NSCLC tissues indicates that CtBP2 is closely related to the occurrence of NSCLC, especially in the lung adenocarcinoma tissues, which is 100% overexpressed, indicating that CtBP2 is highly likely to play an important role in the occurrence and development of lung adenocarcinoma [42]. CTBP2 knockdown results in the activation of p53-dependent apoptosis arrest [43]. A recent study [44] showed that CTBP2 regulates deacetylation of H3K27 to fine control the withdrawal of pluripotency. One of the Ctbp2-binding zinc finger proteins, Zfp217, is known as an oncogenic protein associated with various cancers [45]. Ctbp2 binds to the enhancers and promoters of actively transcribed genes in undifferentiated ESCs that Ctbp2 associates with core components of NuRD and Oct4. These results suggest that Ctbp2 regulates ESC fate by binding to actively transcribed genes [46]. Also, CTBP2 plays a role in cell migration, signal pathways, and the cell cycle. Previous reports indicated that CtBP2 could promote H1299 lung cancer cell migration via repressing PTEN expression and stimulating phosphatidylinositol 3-kinase activity, thereby promoting cell migration [47]. Its overexpression could not only repress the epithelial marker E-cadherin but also upregulate the mesenchymal marker N-cadherin as well as vimentin to enhance migration [48]; in lung cancer cells, it can inhibit the Wnt signaling pathway to promote cell apoptosis and affect the cell cycle [25].This study found that the genotype frequency distribution ofCTBP2 rs3740535 was different between the patient group and the control group. The dominant or recessive genetic model showed that the risk of lung cancer was increased when combined with pollution near the place of residence, house type, COF, ventilation situation, smoking, passive smoking, history of lung disease, or family history of cancer.Our results showed the combined effect of the four genotypes with the environmental factors of pollution near the place of residence, worse ventilation situation, smoking, passive smoking, COF, and family history of cancer. These factors together increase the risk of lung cancer in the population. We did not see an additive interaction between the four locus polymorphisms and smoking. The genotypes were related to the survival outcome of lung cancer patients. The number of protective genotypes of the four loci divided into different groups to evaluate its combined effect with the factors influencing lung cancer in the univariate analysis was also included in the logistic multivariate analysis. Our results showed that unmarried status, BMI, COF, smoking, passive smoking, family history of cancer, and history of lung disease were independent risk factors of lung cancer; college degree or above, no pollution near the place of residence, 1 or 2 protective genotypes, and well ventilation can reduce the occurrence of lung cancer.The sample size was large, and the power of the results was high in the current study. However, our study had limitations. First, we could not completely rule out selection bias, although this was one of the objectives of using three of the largest flow hospitals. Second, the functional studies should be confirmed. Third, environmental factors were significantly different between the two groups, so the relationship between lung cancer and SNPs could not be directly determined. Therefore, the multivariate regression analysis was used for removing the influence of confounders and to explore the relationship between SNPs and lung cancer.


## 5. Conclusion

In conclusion, our study indicated that theOCT4 rs13409 locus was associated with susceptibility to lung cancer, and OCT4 rs13409 CC genotype carriers showed an increased risk of lung adenocarcinoma, whereas OCT4 rs3130932 GG carriers showed an increased risk of squamous carcinoma. However, the conclusion should be further demonstrated in a larger sample size.



---

*Source: 4150263-2019-05-02.xml*